Search
Session handouts and meetings archive
Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Melanoma: Appropriate Surgical Margins ... DESCRIPTION: Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-Melanoma (NCCN Guideline). ... ... MEASURE ID: ... AAD12 ... ... Type: Intermediate
October 3
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 3, 2018 ... Budget bill includes wins for dermatology AAD updates "Find a Dermatologist" tool — have you updated your profile? Are you smarter than DataDerm™? Did CMS miscalculate your
Getting a leg up on squamous cell carcinomas of the teratoacanthoma type
By Warren R. Heymann, MD Oct. 8, 2016 I thought it was my imagination, but apparently not — there is distinct subset of patients, mostly mature women, with squamous cell carcinomas (SCC) of the keratoacanthoma type (KA) usually presenting on the anterior distal lower extremities. ... These patients are not
Are you at risk for pityriasis rubra type V? It’s in the cards!
By Warren R. Heymann, MD Feb. 1, 2017 Characteristic facial involvement in caspase recruitment domain family member 14 gene (CARD14)-associated papulosquamous eruption. Symmetric and geometric pink, scaly patches or plaques involving the cheeks, upper cutaneous lip, and chin with sparing of the infralabial region is highly characteristic of CARD14-associated papulosquamous
CME & session evaluation archive
Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2026 Annual Meeting, Denver, CO, March 27-31, 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual
Secukinumab for pityriasis rubra pilaris: Tread lightly
By Warren R. Heymann, MD Nov. 17, 2016 Every dermatology resident preparing for their board examination can rattle off Griffiths’ classification of pityriasis rubra pilaris (PRP) — Type I (Classical Adult), Type II (Atypical Adult), Type III (Classic Juvenile), Type IV (Circumscribed Juvenile), and Type V (Atypical Juvenile). Type VI,
Other emerging severe and resistant dermatophytes of concern
Overview ... Trichophyton mentagrophytes type VII (TMV ... II ... ) is a recently emerged dermatophyte that is closely related to ... T. indotineae (note: ... T. indotineae was previously called ... T. mentagrophytes type ... VIII ... ). ... 1-3 ... TMVII spreads between people and may be transmitted
Is dyshidrosiform pemphigoid really anti-p200 pemphigoid?
By Warren R. Heymann, MD Aug. 20, 2016 Dyshidrosiform pemphigoid (DP) was initially reported in a 72 year-old man with large, tense bullae on the plantar aspect of his feet, with some lesions on an erythematous base. He also had an "ill-defined papular eruption" of the trunk and an erosion
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Chronic Skin Conditions: Patient Reported Quality-of-Life ... DESCRIPTION: The percentage of patients aged 18 years and older with a chronic skin condition whose self-assessed quality-of-life was recorded at least once in the medical record within the measurement period. ... ... MEASURE ID: ... AAD8 ... ... Type:
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Psoriasis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Dermatitis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient reported itch severity assessments performed, score greater than or equal to 4, and who achieve a score reduction of
Psoriasis: Improvement in Patient-Reported Itch Severity — Measure 485
Psoriasis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient reported itch severity assessment performed, score greater than or equal to 4, and who achieve a score reduction of
Dermatitis: Improvement in Patient-Reported Itch Severity — Measure 486
Dermatitis: Improvement in Patient-Reported Itch Severity ... DESCRIPTION: The percentage of patients, aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient reported itch severity assessments performed, score greater than or equal to 4, and who achieve a score reduction of
Melanoma: Appropriate Surgical Margins — QCDR measure AAD 12
Melanoma: Appropriate Surgical Margins ... DESCRIPTION: Percentage of primary excisional surgeries for melanoma or melanoma in situ with Breslow depth and appropriate surgical margins per the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-Melanoma (NCCN Guideline). ... ... MEASURE ID: ... AAD12 ... ... Type: Intermediate
Advocacy Update Feb 3, 2026
IN THIS ISSUE / Feb. 3, 2026 Dermatologists urged Washington state to support truth in advertising Humana corrects destruction code denials Academy asks CMS to reduce regulatory burdens on dermatology Contribute to SkinPAC Truth in Advertising Dermatologists urged Washington state to support truth in advertising ... The AADA ... urged
Humbled again: Alopecic and aseptic nodules of the scalp
By Warren R. Heymann, MD, FAAD November 3, 2021 Vol. 3, No. 44 "To confess ignorance is often wiser than to beat about the bush with a hypothetical diagnosis." - Sir William Osler I confess. I had never heard of alopecic and aseptic nodules of the scalp (AANS) and have
April 3
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 3, 2019 ... Can the elimination diet hurt pediatric atopic dermatitis patients? DW Insights and Inquiries : Tofacitinib – a JAK inhibitor of all trades Unity in dermatology starts with
Neurofibromatosis type 1, juvenile xanthogranuloma, and leukemia: Wasting a good worry?
By Warren R. Heymann, MD May 22, 2017 A clinically pigmented neurofibroma associated with underlying café au lait macule. ... Credit: ... JAAD Worry comes with the territory of Neurofibromatosis Type I (NF-1). It often starts with the anxiety of determining if a child has enough criteria to confirm the
July 3
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 3, 2019 ... Academy comments on FDA sunscreen proposal DW Insights and Inquiries : Oy, another "Oid" to worry about — cryptococcoid lesions VA launches Community Care Network to provide
Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections
By Warren R. Heymann, MD Aug. 21, 2019 Vol. 1, No. 24 Dermatologists are keenly aware of immunosuppression’s profound biologic effects. Whether by disease or iatrogenic means, clinical vigilance is mandated because of an elevated risk of malignancy, infection, or inflammatory dermatoses. ... In a study of 177 organ transplant
Will PD-1 inhibitors be msed for Mastocytosis?
By Warren R. Heymann, MD May 8, 2016 Kuklinski L, Kim J. Expression of PD-L1 in mastocytosis. J Am Acad Dermatol 2016; 74: 1010-2. ... The authors evaluated 16 specimens from 12 patients with mastocytosis, using immunohistochemical stains for PD-L1, CD-117, and mast cell tryptase on all specimens. Of the12
Glomus tumors point a finger at neurofibromatosis
By Warren R. Heymann, MD ... Nov. 21, 2016 ... The correct diagnosis of the ... JAMA Dermatology Clinicopathological Correlation of a glomus tumor presenting as longitudinal erythronychia was straightforward — I was fascinated by this comment in the discussion: "The presence of multiple glomus tumors in the digits
Time to reassess messing around with steroids and psoriasis
By Warren R. Heymann, MD March 3, 2021 Vol. 3, No. 9 You don't tug on Superman ’ ... s cape You don't spit into the wind You don't pull the mask off that old Lone Ranger And you don't mess around with Jim If the late Jim Croce was
State advocacy win: Step therapy reform enacted in Alaska
A step therapy and prior authorization reform ... bill enacted in Alaska will require insurers to establish a streamlined prior authorization process that minimizes administrative burdens on physicians. The legislation provided a clear and convenient process for requesting exceptions to step therapy protocols and conditions for automatic approval of step
Multiple café au lait spots in fair skinned children without evidence of neurofibromatosis type 1: Don’t SPRE(A)D the word – yet
By Warren R. Heymann, MD Oct. 13, 2016 Café au lait spots (CALS) are extraordinarily common; six or more lesions (at least 0.5 cm prior to puberty or 1.5 cm post puberty) are considered one of the criteria for diagnosing neurofibromatosis type I (NF1), and are also seen in
Is there a best approach to widespread actinic keratoses?
By Deirdre Connolly, MD and Naomi Lawrence, MD April 10, 2019 Vol. 1, No. 5 Journal of the American Academy of Dermatology Volume 72, Issue 2, Pages e57-e59 (February 2015) ... Widespread actinic keratoses (AKs) are problematic to both patients and physicians, not only because of their pre-cancerous nature, but
CMS prior authorization final regulation incorporates AADA’s recommendations
The AADA advocated for these specific prior authorization reforms, which will take effect in 2026. While the regulations currently apply only to Medicare, Medicare Advantage, Medicaid, and CHIP plans and not to private, commercial, and ERISA plans, the AADA anticipates that many private health plans will adopt similar policies. ...
Incretin-based therapy for diabetes and dermatology: Promise and peril
By Warren R. Heymann, MD Oct. 23, 2017 In a given day, how many of your patients are diabetic? According to the American Diabetes Association, in 2015, 9.4% of the US population (30.3 million) were diabetic; 29 million of this group had type 2 diabetes. ... Incretin hormones refer to
Dermatologist job satisfaction
Facts at your Fingertips ... By Emily Margosian, assistant editor, August 1, 2019 Despite rising burnout rates among all physicians, according to the AAD 2019 Life in Practice Study, the vast majority of dermatologists still enjoy what they do. Overall, 72% — or 7 in 10 dermatologists — say they
Plantar melanoma and mechanical stress
By Warren R. Heymann, MD June 15, 2016 Acral lentiginous melanoma (ALM) involves the palms, soles, and nail beds. It is the most common type of melanoma in patients of African or Asian descent. Delays in diagnosis result in more advanced disease at the time of diagnosis. Trauma or chronic
InCYSTing on searching for explosives
By Warren R. Heymann, MD Sept. 8, 2016 I have enjoyed medical writing and editing since publishing my first article in 1983 when I wrote about a penile Fibroepithelioma of Pinkus (my medical school roommate’s father was the patient). Once in a great while, some interest would be generated from
November 3, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Nov. 3, 2021 ... Facial contact dermatitis from cosmetic allergens DermWorld Insights and Inquiries : Humbled again — Alopecic and aseptic nodules of the scalp Derm Coding Consult : Applying 2021
Dermatology antibiotic prescription trends
Facts at your fingertips ... By Emily Margosian, assistant editor, November 1, 2019 As antibiotic resistance has increasingly captured the attention of the media and global health organizations, physicians have found themselves under more pressure to monitor their antibiotic prescription habits. Although overall antibiotic prescribing by dermatologists decreased by 36.6%
Melanoma risk in patients with melaoncortin-1 receptor independent of ultraviolet radiation: Is there a way not to be burned by your genome?
By Warren R. Heymann, MD July 18, 2016 I admit that my concept of Type I skin red-headed patients getting melanoma was simple: They have a polymorphism(s) of the melanocortin-1 receptor (MC1R), pheomelanin, ultraviolet exposure, DNA damage, increased reactive oxygen species, and voila: melanoma! While conceptually elegant, this is apparently
Bad online review?
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatology World explains why bad online reviews may not be so bad after all ... Dermatology World explains why bad online reviews may not be so bad after all ... By Ruth Carol, contributing writer Patients are increasingly
Platelet rich plasma: Good for whatever ails you?
By Warren R. Heymann, MD Jan. 13, 2017 Hair regrowth in ophiasis-type alopecia areata after platelet-rich plasma (PRP) injection. Occipital hair loss before treatment (A) and occipital hair regrowth 3 months after administration of PRP at a concentration 3.5 times above baseline (B). ... Credit: ... JAAD Okay, okay, I
Medical research funding
Ask the Expert ... By Victoria Houghton, managing editor, August 1, 2021 DermWorld ... spoke to Jennifer Mangone, JD, manager of congressional policy for the American Academy of Dermatology Association (AADA), about the Academy’s advocacy efforts to support medical research funding. DermWorld: Advocating for medical research funding is a top
Going green: The complexities of the green nail syndrome
By Warren R. Heymann, MD February 3, 2021 Vol. 3, No. 5 I find a unique satisfaction in diagnosing the green nail syndrome (GNS, aka chloronychia, Goldman-Fox syndrome) — it is easy to recognize and very reassuring to patients who were convinced they had a subungual melanoma. Based on new
Melanoma Reporting — Measure 397
Melanoma Reporting ... DESCRIPTION: The number of pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration, mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ... ... MEASURE ID: ... 397 ... ... Type: Process
Melanoma Reporting — Measure 397
Melanoma Reporting ... DESCRIPTION: The number of pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration, mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ... ... MEASURE ID: ... 397 ... ... Type: Process
Documentation of Current Medications in the Medical Record — Measure 130
Documentation of Current Medications in the Medical Record ... DESCRIPTION: Percentage of visits for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. ... ... MEASURE ID: ... 130 ...
Documentation of Current Medications in the Medical Record — Measure 130
Documentation of Current Medications in the Medical Record ... DESCRIPTION: Percentage of visits for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. ... ... MEASURE ID: ... 130 ...
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Psoriasis: Clinical Response to Systemic Medications ... DESCRIPTION: The percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels. ... ... MEASURE ID: ... 410 ... ... Type: Outcome ... ... CMS Derm Specialty Set: ... Yes ...
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented — Measure 317
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented ... DESCRIPTION: Percentage of adult patients who were screened for high blood pressure and received a follow-up plan where indicated. ... ... MEASURE ID: ... 317 ... ... Type: Process ... ... CMS Derm
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Closing the Referral Loop: Receipt of Specialist Report ... DESCRIPTION: The percentage of patients with referrals during the reporting period whose referring physician received a report back from the other physician. ... ... MEASURE ID: ... 374 ... ... Type: Process ... ... CMS Derm Specialty
Psoriasis: Clinical Response to Systemic Medications — Measure 410
Psoriasis: Clinical Response to Systemic Medications ... DESCRIPTION: The percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels. ... ... MEASURE ID: ... 410 ... ... Type: Intermediate outcome ... ... CMS Derm Specialty Set: ... Yes
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon – Part II – Focus on Anifrolumab
By Warren R. Heymann, MD, FAAD Sept. 13, 2023 Vol. 5, No. 37 This is an exciting time for cutaneous lupus erythematosus (CLE). Recently published findings from three clinical trials show substantial progress in developing more targeted, efficacious, and better-tolerated medications for patients with CLE, particularly by inhibiting the production
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Patient-Centered Surgical Risk Assessment and Communication ... DESCRIPTION: The percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed and discussed prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon. ...
Patient-Centered Surgical Risk Assessment and Communication — Measure 358
Patient-Centered Surgical Risk Assessment and Communication ... DESCRIPTION: The percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed and discussed prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon. ...
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis ... DESCRIPTION: Percentage of patients with a diagnosis of severe psoriasis without a documented Body Surface Area (BSA) or a documented BSA greater than 10% for whom phototherapy or an oral systemic or biologic medication was prescribed. ... ... MEASURE ID:
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis — QCDR measure AAD15
Psoriasis: Appropriate Assessment & Treatment of Severe Psoriasis ... DESCRIPTION: Percentage of patients with a diagnosis of severe psoriasis without a documented Body Surface Area (BSA) or a documented BSA greater than 10% for whom phototherapy or an oral systemic or biologic medication was prescribed. ... ... MEASURE ID:
Closing the Referral Loop: Receipt of Specialist Report — Measure 374
Closing the Referral Loop: Receipt of Specialist Report ... DESCRIPTION: The percentage of patients with referrals during the reporting period whose referring physician received a report back from the other physician. ... ... MEASURE ID: ... 374 ... ... Type: Process ... ... CMS Derm Specialty
Screening for Social Drivers of Health — Measure 487
Screening for Social Drivers of Health ... DESCRIPTION: Percent of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety. ... ... MEASURE ID: ... 487 ... ... Type: Process ... ... CMS Derm Specialty Set: ...
Skin conditions by the numbers
Acne ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (2) A
Use of High-Risk Medications in Older Adults — Measure 238
Use of High-Risk Medications in Older Adults ... DESCRIPTION: Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. ... ... MEASURE ID: ... 238 ... ... Type: Process ... ... CMS Derm Specialty
Adult Immunization Status — Measure 493
Adult Immunization Status ... DESCRIPTION: Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; and pneumococcal. ... ... MEASURE ID: ... 493 ... ... Type: Process
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Skin Cancer: Biopsy Reporting Time — Clinician to Patient ... DESCRIPTION: The percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal, squamous cell carcinoma, or melanoma (including in situ disease), or primary cutaneous malignancies who are notified of their final biopsy pathology findings within less than
Biopsy: Reporting Time - Clinician to Patient — QCDR measure AAD 6
Skin Cancer: Biopsy Reporting Time — Clinician to Patient ... DESCRIPTION: The percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal, squamous cell carcinoma, or melanoma (including in situ disease), or primary cutaneous malignancies who are notified of their final biopsy pathology findings within less than
Key messaging in social media about acne
Key messages ... Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. (1) ... There are different types of acne (blackheads, whiteheads, pimples, acne cysts or nodules), so a one-size-fits-all approach is not the best way to achieve clearer skin. (1)
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes — QCDR measure AAD 20
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes ... DESCRIPTION: Percentage of adult patients (18 years old and older) who self-report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis (AK) and who self-report satisfaction with the treatment or management of AK. Patients provide a global
Advance Care Plan — Measure 47
Advance Care Plan ... DESCRIPTION: Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not
Advance Care Plan — Measure 47
Advance Care Plan ... DESCRIPTION: Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not
Adult Immunization Status — Measure 493
Adult Immunization Status ... DESCRIPTION: Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; pneumococcal; and hepatitis B. ... ... MEASURE ID: ... 493 ... ...
May 3, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 3, 2023 ... Oral oxybutyloride for hidradenitis suppurativa patients? DermWorld Insights and Inquiries : Necrobiosis lipoidica in a Wink Exposure to anesthesia and alopecia areata Do study authors accurately report
April 3, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 3, 2024 ... Safety of DEET insect repellent in children: Do the natural alternatives work? DermWorld Insights and Inquiries : Hair straightening and acute renal injury — The latest data
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling ... DESCRIPTION: The percentage of adult patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months and received brief counseling if identified as an unhealthy alcohol user. ...
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling — Measure 431
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling ... DESCRIPTION: The percentage of adult patients who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months and received brief counseling if identified as an unhealthy alcohol user. ...
Decomplexing plexiform neurofibromas
By Warren R. Heymann, MD Dec. 29, 2016 Plexiform neurofibromas (PNs) are some of the most disfiguring and therapeutically challenging lesions that dermatologists confront. PNs are mostly associated with autosomal dominant neurofibromatosis type 1. Rarely, they may also be seen in germline p16 mutation-positive heritable melanoma and Cowden syndrome. Diffuse
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection — QCDR measure AAD 18
Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection ... DESCRIPTION: Percentage of procedures in patients, aged 18 and older with a diagnosis of skin cancer, who had intermediate layer and/or complex linear closures OR reconstruction after skin cancer resection where opioid/narcotic therapy was prescribed as first
Do skin cancer rates differ by transplanted organ type and patient age?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, March 1, 2023 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Lee Wheless, MD,
Chronic Skin Conditions: Patient Reported Quality-of-Life — QCDR measure AAD8
Chronic Skin Conditions: Patient Reported Quality-of-Life ... DESCRIPTION: The percentage of patients aged 18 years and older with a chronic skin condition whose self-assessed quality-of-life was recorded at least once in the medical record within the measurement period. ... ... MEASURE ID: ... AAD8 ... ... Type:
Controlling High Blood Pressure — Measure 236
Controlling High Blood Pressure ... DESCRIPTION: Percentage of patients 18–85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled (<140/90 mmHg) during the measurement
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD 17
Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer, on prescribed anticoagulation therapy, who had intermediate layer and/or complex linear closures OR reconstruction after skin
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Skin Cancer: Biopsy Reporting Time — Pathologist to Clinician ... DESCRIPTION: The percentage of biopsies with a diagnosis of cutaneous BCC, SCC, or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within seven days from receipt of the tissue specimen. ... ... MEASURE
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time — Pathologist to Clinician — Measure 440
Skin Cancer: Biopsy Reporting Time — Pathologist to Clinician ... DESCRIPTION: The percentage of biopsies with a diagnosis of cutaneous BCC, SCC, or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within seven days from receipt of the tissue specimen. ... ... MEASURE
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention — Measure 226
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention ... DESCRIPTION: The percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period and who received tobacco cessation intervention during the measurement period or in the six months
The retiring type?
By Warren R. Heymann, MD April 23, 2017 "Tell me, Dr. Heymann, when do you plan to retire?" ... Patients seem to ask me that every day. ... My usual response: "Why do you ask, do I look that bad?" ... "No, you look pretty good for your age." (According
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Gains in Patient Activation Measure (PAM®) Scores at 12 Months ... DESCRIPTION: The Patient Activation Measure (PAM) is a 10- or 13-item questionnaire that assesses an individual’s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer who underwent intermediate layer, complex linear closure, or reconstruction after skin cancer resection in the office-based setting (not
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures — QCDR measure AAD16
Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures ... DESCRIPTION: Percentage of procedures in patients aged 18 and older with a diagnosis of skin cancer who underwent intermediate layer, complex linear closure, or reconstruction after skin cancer resection in the office-based setting (not
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Melanoma: Tracking and Evaluation of Recurrence ... DESCRIPTION: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating provider examines and/or diagnoses the
Melanoma: Tracking and Evaluation of Recurrence — Measure 509
Melanoma: Tracking and Evaluation of Recurrence ... DESCRIPTION: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating provider examines and/or diagnoses the
Gains in Patient Activation Measure (PAM) Scores at 12 Months — Measure 503
Gains in Patient Activation Measure (PAM®) Scores at 12 Months ... DESCRIPTION: The Patient Activation Measure (PAM) is a 10- or 13-item questionnaire that assesses an individual’s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to one
Triskaidekaphobia legitimized: Fatal Factor XIII deficiency
By Warren R. Heymann, MD, FAAD April 12, 2023 Vol. 5, No. 15 I am not especially superstitious. The number 13 has never concerned me but acquired Factor XIII deficiency has now joined my ever-expanding pantheon of new complications to worry about. ... The article entitled "Association of lethal acquired
October 12, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Oct. 12, 2022 ... Type 2 diabetes and CCCA severity DermWorld Insights and Inquiries : Fixing the concept of the neutrophilic fixed drug eruption What’s the risk of IBD in patients
Addressing systems and administrative challenges
Running a successful dermatology practice hinges not only on exceptional patient care but also on efficient administration. While challenges vary based on practice type and other factors, most practices face common administrative burdens. These burdens are a major driver of burnout. ... Surveys conducted among Academy members between 2016-2020 revealed
Clear cell papulosis: Clearly distinctive, clearly underrecognized
By Warren R. Heymann, MD June 3, 2020 Vol. 2, No. 22 One of my greatest joys in dermatology is diagnosing a disease that I have only read about, but then encounter in life. That "aha moment" is exhilarating! When attending patient presentations at dermatology conferences, I encourage my residents
Biotin supplementation for hair and nail health: Does it pass the test?
By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,
Connection to Community Service Provider — Measure 498
Connection to Community Service Provider ... DESCRIPTION: Percent of patients 18 years and older who screened positive for one or more of the following health-related social needs: food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety and had contact with a Community Service Provider for at least one
January 3, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 3, 2024 ... Efficacy of minoxidil for cancer treatment–induced hair loss DermWorld Insights and Inquiries : Malignant syphilis — History in the making Most effective medications for plaque psoriasis Cardiovascular,
Vascular Ehlers-Danlos syndrome: From rupture to rapture?
By Warren R. Heymann, MD, FAAD February 16, 2022 Vol. 4, No. 7 If there was a statistic for a dermatological diagnostic impact factor, vascular Ehlers-Danlos syndrome (vEDS) would be at the top. Often undiagnosed until tragedy strikes, astute dermatologists who consider the diagnosis prior to an acute event may
March 3, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 3, 2021 ... The latest on the association between diet and acne DermWorld Insights and Inquiries : Time to reassess messing around with steroids and psoriasis Is intralesional 5-FU effective
Teatime for radiation dermatitis (and beyond)
By Warren R. Heymann, MD, FAAD June 14, 2023 Vol. 5, No. 24 I am biased — as a coffee lover, I only believe articles demonstrating coffee’s benefits, while finding flaws in any study deriding its use. I can be more objective about tea — especially green tea — a
August 3, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 3, 2022 ... Dutasteride microinjections with oral minoxidil vs. oral minoxidil for androgenetic alopecia DermWorld Insights and Inquiries : Infantile digital fibromatosis – Inclusions and exclusions CMS outlines payment changes
February 3, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 3, 2021 ... How effective are oral hair growth supplements? DermWorld Insights and Inquiries : Going green — The complexities of the green nail syndrome A practical guide for managing
A single case report has the potential to change the world: Could JAK inhibition alter the trajectory of multicentric reticulohistiocytosis?
By Warren R. Heymann, MD, FAAD Aug. 3, 2022 Vol. 4, No. 31 In 1965, Reye described 18 small, fibrous tumors from 12 children submitted to his laboratory for histological examination, that he had accumulated over two decades. Initially, these lesions were tentatively classified as well-differentiated fibrosarcomas. His seminal observation
Ustekinumab: A topic for atopics?
By Warren R. Heymann, MD Jan. 9, 2017 Atopic dermatitis patient shows drastic improvement at week 19 of ustekinumab treatment. ... Credit: ... JAAD If you’re like me, you have a cadre of patients with severe atopic dermatitis (AD) patients who are counting the minutes for the release of
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience — QCDR measure AAD 20
Actinic Keratosis: Self-reported AK Treatment or Management Outcomes - National Quality Strategy Domain: Patient Experience ... DESCRIPTION: Percentage of adult patients (age 18 years and older) who report favorable outcomes resulting from a recommended treatment or management approach for Actinic Keratosis. Patients provide a global assessment of the perceived effectiveness
July 3, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 3, 2024 ... Tazarotene vs. imiquimod in patients with plane warts DermWorld Insights and Inquiries : Fire ant stings: From pain to gain — The therapeutic potential of solenopsin Efficacy
September 3, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 3, 2025 ... Comparison of botulinum toxin A formulations for treating glabellar strain DermWorld Insights and Inquiries : Trichobacteriosis — A salute to the Shelleys Academy mourns the passing of
December 3, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 3, 2025 ... GLP-1s and telogen effluvium DermWorld Insights and Inquiries : Pityriasis rosea and pityriasis rosea-like eruptions — A Christmas tale Combination oral minoxidil and baricitinib for alopecia areata
June 3, 2026
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 3, 2026 ... Risk of cardiovascular events with 5-alpha-reductase inhibitors in androgenetic alopecia DermWorld Insights and Inquiries : A potential roadMAP for treating malignant atrophic papulosis Yellow nail syndrome: Diagnosis
June 3, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 3, 2020 ... COVID-19 and androgenetic alopecia: Is there a link? DW Insights and Inquiries : Clear cell papulosis — Clearly distinctive, clearly underrecognized Register for the Academy’s virtual meeting
October 23, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 23, 2024 ... Botulinum toxin type A with topical minoxidil vs. topical minoxidil alone in males with androgenetic alopecia DermWorld Insights and Inquiries : Shocking news — Heat shock protein
Compounding toolkit
Can you compound or prescribe it? ... Answer a few questions below to determine whether the type of compounding you are performing is in compliance with Food & Drug Administration (FDA) regulations and how to access the drug product if it cannot be compounded in your office. ... Are you
New treatments provide more options for people with alopecia areata
Journal of the American Academy of Dermatology ... article highlights new ways to restore hair ROSEMONT, Ill. (Aug. 15, 2023) — A study published today in a supplement of the ... Journal of the American Academy of Dermatology titled " ... Alopecia: A New Frontier " reveals that a new
New study reveals that some children with common form of eczema should also be tested for allergic reactions
Study author highlights test used to differentiate between two types of eczema ROSEMONT, Ill. (September 26, 2023) — Eczema, which is a group of medical conditions that causes inflamed, irritated, and often itchy skin, affects millions of people worldwide. A new article published in the ... Journal of the American
A shot in the dark
By Danielle M. DeHoratius, MD March 10, 2021 Vol. 3, No. 10 Danielle DeHoratius, MD ... For the past few Mondays, I have been asked to see the following "emergency" patients who called in with the diagnosis of cellulitis after the COVID-19 vaccination. Typically, these patients were seen in urgent
Biopsy coding in 2019: Part 3
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, January 1, 2019 Test your knowledge: Biopsy coding in 2019 — Part 3 ... Take the quiz to see
Necrobiosis lipoidica in a Wink
By Warren R. Heymann, MD, FAAD May 3, 2023 Vol. 5, No. 18 Ninety years have transpired since Urbach coined the term ... necrobiosis lipoidica diabeticorum (NLD) for the granulomatous disorder first described by Oppenheim in 1929 as ... dermatitis atrophicans lipoidica diabetica . (1) Early authors observed sclerotic plaques
Evaluation and management in 2021: Part 3
Cracking the code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, November 1, 2020 Test your knowledge: Evaluation and management in 2021: Part 3 ... Take the quiz to see
Lagging ahead: LAG-3 checkpoint inhibition for advanced melanoma
By Warren R. Heymann, MD, FAAD May 11, 2022 Vol. 4, No. 19 Checkpoint inhibition has revolutionized the treatment of advanced melanoma over the past decade, beginning with the release of the anti-CTLA4 checkpoint inhibitor ipilimumab (Yervoy). This was followed by the development of the anti-PD-1 inhibitors pembrolizumab (Keytruda) and
3 ways to promote skin cancer awareness this month
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... May is Skin Cancer Awareness Month, and all month long the AAD is asking Americans "Do You Use Protection?" and encouraging the public to "practice safe sun." Use the Academy’s new SPOT Skin Cancer™ resources
Appropriate Documentation and Shared Decision Making of AK — QCDR measure AAD 21
Actinic Keratosis: Appropriate Documentation and Shared Decision Making of AK ... DESCRIPTION: Percentage of adult patients (18 years old and older) diagnosed with Actinic Keratosis (AK) whose healthcare provider has recorded the following information in the patient’s medical record 1) documentation of the number or range of AKs, 2) location(s)
Advocacy Update Jun 3, 2025
IN THIS ISSUE / June 3, 2025 AADA advocates for revisions to CLIA lab director requirements AADA urges DOJ to tackle Medicare payment reforms and CLIA lab director restrictions Advocacy win: Step therapy reform law enacted in New Jersey Become an AADA Advocacy Key Contact Support SkinPAC to elect dermatology
Advocacy Update March 3, 2026
IN THIS ISSUE / March 3, 2026 Dermatology pursues immediate CMS action, LCD reconsideration on SRT training AADA, NY dermatologists oppose lab director requirements Watch your inbox for an important AADA RUC survey AADA presents at FDA’s annual compounding listening session Dermatologists urge support for Rhode Island step therapy reform
Waiting for Wong
By Warren R. Heymann, MD ... Oct. 6, 2016 ... The Wong variant of dermatomyositis was originally described by O’Leary during the Eisenhower administration (1953) and named for Wong during Nixon’s tenure (1969). I have been involved with dermatology since Carter’s term in office (1979). Since that time (Reagan,
Sézary syndrome and Shakespeare: What’s in a name?
By Warren R. Heymann, MD ... March 24, 2017 ... Initial clinical presentations of Sézary syndrome without erythroderma. Normal-appearing skin with moderate pigmentation on back of patient 2 (A), several seborrheic keratoses and a hematoma secondary to skin biopsy for patient 3 (B), no apparent lesion on back of
This month’s news from across the specialty
What’s hot ... March 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Harry Dao Jr., MD, FAAD Injectable biologics remain the gold standard for achieving optimal clinical responses in psoriasis, but fear of injections leads many
What are keratoacanthomatous lesions of the legs in mature women?
By Warren R. Heymann, MD Dec. 11, 2017 ... Right thigh, keratoacanthomatous atypical squamous proliferation. (Hematoxylin-eosin stain; original magnification: ×10.) ... Credit: ... JAAD I have an increasing number of patients asking me questions about proliferating keratoacanthoma-like lesions on their shins. "Why am I getting these? Are they cancer? Why
Cannabinoids may elevate therapy for connective tissue diseases to a higher level
By Warren R. Heymann, MD Nov. 2, 2017 Medical "reefer madness" is taking hold in the United States with approximately 10% of cannabis users utilizing it for diverse medical conditions, including dermatologic disorders such as pruritus and atopic dermatitis. To date, at least 28 states allow for the use of
Becoming pro-geriatric by understanding progeria
By Warren R. Heymann, MD Aug. 13, 2018 A fifteen-year-old boy with Hutchinson-Gilford progeria syndrome. ... Credit: ... JAAD I have never seen a case of Hutchinson-Gilford progeria syndrome (HGPS). You probably haven’t either, given its incidence of 1 in 4 million. Why comment on a disease that will likely
Maximizing knowledge about infantile hemangioma with minimal or arrested growth
By Warren R. Heymann, MD Feb. 3, 2017 Areas affected by segmental infantile hemangioma (IH) and IH with minimal or arrested growth (IH-MAG) of the arms (A to E) with correlating arterial supply areas. ... Credit: ... JAAD Knowledge about hemangiomas is proliferating at a rate the compares with the
Tressed to impress: tips for keeping your mane magnificent
6 tips for healthier looking and feeling hair from a board-certified dermatologist ROSEMONT, Ill. (Aug. 13, 2024) — Hair is as unique as its wearer, making care an important aspect in one’s overall health and wellness routine. From understanding your hair type to learning the best shampooing technique (yes, there
Caveat mTOR revisited: Neurofibromatosis
By Warren R. Heymann, MD, FAAD Feb. 14, 2024 Vol. 6, No. 7 An abridged version of this commentary was published in "A Clinician's Perspective" in the April 2023 issue of the JAAD. ... It is understandable how dermatologists may forget about many details of rare genodermatoses after taking their
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy ... DESCRIPTION: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month
Tofacitinib for dermatomyositis: A potential belle of the ball?
By Warren R. Heymann, MD Aug. 23, 2016 JAK1/3 signaling participates in the pathogenesis of inflammatory disorders while JAK1/2 signaling plays a role in the development of several malignancies including leukemias, lymphomas, and myeloproliferative neoplasms. Tofacitinib (Xeljans) is a pan-JAK inhibitor that is approved by the FDA for the treatment
Focusing attention on X-linked ichthyosis
Ichthyosis vulgaris ... Credit: ... JAAD By Warren R. Heymann, MD Jan. 2, 2019 I thought it was me. Like every dermatologist, I learned the classical appearance of the ichthyoses, and wonder why I’m not sure if I am looking at a patient with ichthyosis vulgaris (IV) or X-linked ichthyosis
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy — Measure 176
Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy ... DESCRIPTION: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month
Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
By Warren R. Heymann, MD, FAAD April 17, 2024 Vol. 6, No. 16 Glucagon-like peptide-1 (GLP-1) receptor agonists — your patients are on them, and perhaps you are too (or at least have thought about it). In 2023, more than 500 million people worldwide were afflicted with obesity and type
AADA advocates for innovative teledermatology policies and programs
While 85 million Americans are impacted by skin disease, only 1 in 3 patients will see a dermatologist. The Academy believes that teledermatology is a powerful tool for increasing patient access to needed dermatologic care. ... The Academy advocates for innovative teledermatology policies and programs that increase access to care
Methotrexate toxicity: What’s in a name?
By Warren R. Heymann, MD Aug. 24, 2017 Methotrexate-induced skin toxicity: photographs of 4 illustrative cases. A, Erosions in psoriatic plaques over the torso (patient 1). B and C, Ulcerated and reticulated psoriatic plaques over the arms (patient 2). D, Small shallow cutaneous erosions (patient 4). E, Mucosal erosions over
Hair straightening and acute renal injury: The latest data straight up
By Warren R. Heymann, MD, FAAD April 3, 2024 Vol. 6, No. 14 The global hair straightener market has experienced significant growth, with a market size of US$ 587.9 million in 2022, projected to be US$ 759.9 million by 2028. (1) I expected the market to already be in the
The alphabetization of lymphomatoid papulosis: Focus on “F”
By Warren R. Heymann, MD April 3, 2017 Follicular lymphomatoid papulosis. Recurrent papulonodular lesions on face (A to C). Patient had similar lesions on extremities. ... Credit: ... JAAD Seven years ago, today (April 3rd, 2010) my wife purchased an iPad on its inaugural release date. The only choices to
Olmsted syndrome patients can finally put their foot down
By Warren R. Heymann, MD January 20, 2021 Vol. 3, No. 3 Reading Olmsted’s seminal paper entitled "Keratodermia Palmaris et Plantaris Congenitalis" is captivating reading on multiple levels. In that era of descriptive dermatology, there is an allure in how he differentiates his patient from keratodermas described by the giants
Transplantation dermatology: Race matters
By Warren R. Heymann, MD June 21, 2017 African American man with generalized vitiligo. Medial aspect of foot before (A) and 5 months after (B) melanocyte-keratinocyte transplantation procedure. ... Credit: ... JAAD December 3rd, 2017 will mark the 50th anniversary of the first human-to-human heart transplant performed by the late
Atrophic tinea versicolor: Knowledge about its pathogenesis is hypertrophying
By Warren R. Heymann, MD April 12, 2017 In the entry "Atrophic Tinea Versicolor: More Than a Mirage" (April 22, 2016), I learned that the atrophic appearance of some cases of tinea versicolor is not just an optical illusion. The case of a 35-year-old man with depressed brown lesions on
Malpractice insurance 101
Experts offer advice on navigating malpractice insurance policies. ... Feature ... By Andrea Niermeier, Contributing Writer, February 1, 2025 While medical malpractice suits first regularly appeared in the United States in the 1800s, the frequency of claims has only increased since the 1960s, with lawsuits relatively common today. Medical malpractice
The nexus of VEXAS syndrome
By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS
This month’s news from across the specialty
What’s hot ... August 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Maureen Offiah, MD, FAAD Several physician groups have recently modified the ... staging and classification of all primary cutaneous lymphomas (PCL). Changes to
April 17
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 17, 2019 ... Having trouble accessing compounded quinacrine tablets? Here’s why. DW Insights and Inquiries : A ‘pregnant pause’ is necessary before concluding on the obstetric risk of vitiligo Lessons
Studying skin aging never gets old: The potential role of oxytocin
By Warren R. Heymann, MD Oct. 14, 2020 Vol. 2, No. 41 Every day, dermatologists address patient concerns about their aging skin — whether they are presenting for medical, surgical, or cosmetic problems. Extrinsic factors such as ultraviolet light and smoking resulting in a leathery, coarsely wrinkled appearance are well
2020 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... December 23 - 2020 holiday greeting December 16 - We’re in hot water! Vibrio vulnificus infections are heading north December 9 - Much ado about nothing in dermatopathology December 2 - Pigmented onychomatricoma: Avoid getting nailed by
Coming to terms with Louis Brocq and his diagram: Pityriasis lichenoides 2018
By Warren R. Heymann, MD July 16, 2018 ... A and B, Pityriasis lichenoides chronica–like drug eruption. The lower legs show several, 3- to 4-mm, red-brown, thin papules with centrally adherent micaceous scale and intermixed erosions. ... Credit: ... JAAD As a first-year dermatology resident in 1980, I struggled with
Lipschütz ulcers: Not only for women
By Warren R. Heymann, MD March 24, 2021 Vol. 3, No. 12 Superstar dermatologists do not throw softball questions to presenters at the Annual Meeting of the American Academy of Dermatology. A few years ago, following my presentation on the cutaneous manifestations of Epstein-Barr infection, Dr. Jeffrey Callen, one of
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with
Taking woolly hair to heart
By Warren R. Heymann, MD, FAAD October 27, 2021 Vol. 3, No. 43 Woolly hair (WH) appears as strongly coiled hair — it may be localized or diffuse, with the latter often associated with syndromes affecting the heart, gastrointestinal tract, or central nervous system. ... This commentary will briefly touch
Getting to the heart of neonatal lupus erythematosus
By Warren R. Heymann, MD, FAAD July 21, 2021 Vol. 3, No. 29 I have found that rendering the diagnosis of neonatal lupus erythematosus (NLE) is fraught with emotional challenges. Not only are mothers concerned for their children, frequently they are unaware of the fact that they are also at
A dermatologic riddle: How is IgG4-related ophthalmic disease parliamentary?
By Warren R. Heymann, MD March 22, 2017 Immunostains of infiltrate. A, Immunostain shows an infiltrate rich in IgG4+ plasma cells. The infiltrate had an IgG4+ cell count of 80 per HPF and an IgG4+/IgG+ ratio of 80%. B, IgG immunostain shown for comparison. (A and B, original magnifications:
My fair-weather therapeutic friends for alopecia areata
By Warren R. Heymann, MD April 25, 2017 Type C clinical pattern of alopecia. A, Patchy hair loss on a background of a diffuse hair loss with (B) occipital involvement in an ophiasis-like pattern. C, Biopsy specimen obtained from the vertex of the scalp. Histopathology of vertical sections shows an
AAD letter to the New York Times in response to “3 Medical Routines that Older People May Not Need”
American Academy of Dermatology President Murad Alam, MD, MSCI, MBA, FAAD Letter to the editor originally submitted to the New York Times ... on May 4, 2026 ROSEMONT, Ill. (May 4, 2026) — 3 Medical Routines that Older People May Not Need , by Paula Span, imprudently suggests that patients
Shedding light on the hydroa vacciniforme-like lymphoproliferative disorder
By Warren R. Heymann, MD, FAAD Sept. 1, 2021 Vol. 3, No. 35 Hydroa vacciniforme (HV) has always mystified me in every respect — its clinical presentation, pathophysiology, prognosis, and even its name. I understand "vacciniforme" because residual scars may resemble those of smallpox. I was surprised to learn that
Reporting Quality for MIPS
The tracking of quality measures and the implementation of improvement activities can help to lead to improved outcomes in patient care and care processes. ... Quality measures ... AAD continues to expand the number and type of dermatology-specific measures for reporting to CMS. Access a complete list of MIPS measures
Are teens tanning less?
Go to AAD Home ... Go to AAD Home ... Menu ... Signs point to progress, but work remains ... Signs point to progress, but work remains ... By Ruth Carol, contributing writer It appears that fewer teens are indoor tanning in recent years, but the data are sparse. Regulations
Keeping abreast of drug-induced cutaneous lupus
By Warren R. Heymann, MD, FAAD Aug. 4, 2021 Vol. 3, No. 31 Tom Hanks, as Commander Jim Lovell in the movie ... Apollo 13, lamented that the world was not watching their onboard video, compared to Neil Armstrong’s moon landing a year earlier. Reality dictates that the seminal breakthroughs
As molecular knowledge of PROS expands, lesions contract
By Warren R. Heymann, MD April 19, 2018 PIK3CA patient showing hemifacial hypertrophy. ... Credit: ... JAAD Somatic activating mutations in the phosphatidylinositol-3-kinase/AKT/mTOR pathway manifest as heterogeneous segmental overgrowth phenotypes Historically, the clinical diagnoses in patients with PIK3CA activating mutations have included Fibroadipose Hyperplasia or Overgrowth (FAO), Hemihyperplasia Multiple Lipomatosis
August 8, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 9, 2023 ... Emerging treatments for itch in atopic dermatitis DermWorld Insights and Inquiries : Prior authorization audits and innovations — Are we finally reducing the (PA)in? Adverse events in
Epidemic of melanoma or epidemic of scrutiny?
By Jason B. Lee, MD May 19, 2021 Vol. 3, No. 20 The goal of population screening is to detect cancers at their early stages to prevent the associated morbidity and mortality of the late stages. The efforts to detect melanoma in its early stages went into full gear over
Metformin mania: Is it an adequate chemopreventive agent for skin cancer?
By Warren R. Heymann, MD, FAAD Aug. 31, 2022 Vol. 4, No. 35 Precisely a century ago (in 1922) metformin was synthesized, based on the folk knowledge that the active, but toxic constituent guanidine galegine, (derived from French lilac, ... Galega officinalis ) could treat "sweet urine." Metformin is now
Tennessee legislation increases transparency
Tennessee Gov. Bill Lee (R) signed legislation limiting the use of medical specialty titles in advertisements. ... The new state law requires any advertisement for health care services to include the name of a health care practitioner and the type of licensure or profession held. The AADA believes that all
Improvement activities (15%)
In this performance category, clinicians are rewarded for care focused on care coordination, beneficiary engagement, and patient safety. For 2026 MIPS reporting, this category is worth 15% of the MIPS score with a maximum of 40 points available. There are 67 dermatology-relevant practice improvement activities (IAs) to choose from. ...
Diagnosing pyoderma gangrenosum? Consider cocaine/levamisole as a potential culprit!
By Warren R. Heymann, MD May 1, 2016 The authors presented 8 patients with PG following exposure to levamisole-contaminated cocaine. All patients had lower extremity involvement, and 6 also had PG on the upper extremities. Retiform purpura was only observed in 3 patients. Most had elevated titers for p-ANCA and
AAD Event Advertising: Annual Meeting
The Academy's Annual scientific meeting offers unprecedented access to thousands of dermatologists attending high-profile continuing medical education events. ... For exhibitors looking to promote their products and services, build booth traffic, and facilitate face-to-face discussions, the Academy offers a wide selection of high-impact advertising opportunities. Look here for advertising opportunities
Cimetidine offers a ray of sunshine for patients With erythropoietic protoporphyria
By Warren R. Heymann, MD Nov. 16, 2016 Only once in a great while an article makes me want to break into my happy dance — the report of 3 pediatric cases of erythropoietic protoporhyria (EPP) by Tu et al had that effect. Recently, I ran a post on EPP
COVID-19 can nail you in so many ways
By Elizabeth Yim, MD, MPH, FAAD, and John Montgomery Yost, MD, MPH, FAAD July 13, 2022 Vol. 4, No. 28 Dr. Elizabeth Yim and Dr. John M. Yost. ... During these difficult and quite frankly, scary times, we have heard numerous reports of various cutaneous manifestations by the SARS-COV-2 infection
Looking beyond ‘Ozempic face’
Dermatologists weigh in on cutaneous side effects of GLP-1 agonists. ... Feature ... By Emily Margosian, Senior Editor, November 1, 2025 Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body
Tofacitinib: A JAK inhibitor of all trades
By Warren R. Heymann, MD April 3, 2019 Vol. 1, No. 4 The Janus kinase inhibitors are taking the dermatologic therapeutic world by storm — at least in the literature. By now, most dermatologists are familiar with studies that have demonstrated efficacy in alopecia areata, vitiligo, psoriasis, psoriatic arthritis, and
Membership Committee portal
Welcome to the American Academy of Dermatology’s Membership Committee portal. The portal houses applications and their supporting documentation along with resources to help determine eligibility for membership. ... Applicant Name ... Type ... Category ... Country ... Status ... Review {{application.fullName}} ... {{application.pendingMemberType}} ... {{application.pendingMemberCategory}} ... {{application.businessAddressCountry}} ... {{application.status}} ...
LIDA* rose the insulin requirement
By Warren R. Heymann, MD April 14, 2021 Vol. 3, No. 15 * Localized insulin-derived amyloidosis ... Amyloidosis, I thought I knew ye. But alas, you fooled me again. ... Amyloid is an insoluble protein folded in ... β -pleated sheets that is deposited extracellularly. Amyloid can accumulate in one
May 1
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 1, 2019 ... FDA approves two new psoriasis treatments ... DW Insights and Inquiries : When assessing morbilliform eruptions think about morbilli (measles)! We want your feedback: Draft psoriasis guidelines
July 31, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 31, 2024 ... Does an increase in omega-3 fatty acids improve acne? DermWorld Insights and Inquiries : Which treatment modality of pyogenic granuloma is worth its weight in salt? Is
Learning module: Genetic skin diseases
Goals and objectives ... The purpose of this module is to help develop a clinical approach to the evaluation and initial management of patients presenting with genodermatoses. ... By completing this module, the learner will be able to: ... Identify and describe the morphology of skin lesions typical of tuberous
Spot on! Lentigines in resolved psoriatic plaques
By Warren R. Heymann, MD Nov. 30, 2016 Having treated psoriatic patients throughout my career, there have been innumerable occasions where patients were concerned about pigmentary changes following successful treatment of the plaques. I have usually reassured them that these are postinflammatory pigmentary alterations that should abate with time. Recently,
An encapsulation of palisaded encapsulated neuromas
By Warren R. Heymann, MD, FAAD Jan. 22, 2025 Vol. 7, No. 3 You know the drill — a patient presents with a solitary, slowly enlarging, dome-shaped, non-pigmented painless facial papule and asks, "Is it skin cancer?" Your clinical and dermoscopic examinations are not definitive, so you respond with uncertainty,
Unrestricted fascination with restrictive dermopathy
By Warren R. Heymann, MD, FAAD Nov. 16, 2022 Vol. 4, No. 46 Barely a week into our fellowships at the University of Pennsylvania in 1984, my wife (a geneticist) asked her favorite dermatologist (me) if I had any thoughts about a neonate with skin that was thin, taut, and
March
Issue ... March January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... I always knew firefighting was a dangerous occupation What’s hot ... This month’s news from across the specialty Clinical Applications ... Do skin cancer
Beware: Discordance abounds among pathologists in the diagnosis of melanocytic neoplasms
By Jason B. Lee, MD Dec. 4, 2019 Vol. 1, No. 38 Discordance in the histological diagnosis of melanocytic lesions has been an underemphasized and understudied problem, and, therefore, the scale and the impact of the problem is largely unknown. Over the years, there were small studies and observations suggesting
Homing in on hornerin: Breaking down the barrier to understand its crucial role in atopic dermatitis
By Warren R. Heymann, MD, FAAD Oct. 16, 2024 Vol. 6, No. 42 Atopic dermatitis (AD) is characterized by skin barrier dysfunction, inflammation, and chronic pruritus. The etiology of AD, however, is complicated and incompletely understood, with genetic, environmental (soaps, surfactants, stress), and immunological factors causing skin barrier abnormalities and
What are the effects of nemolizumab treatment in prurigo nodularis patients?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, FAAD, July 1, 2024 In this month’s Clinical Applications column, DermWorld ... Physician Editor Kathryn Schwarzenberger, MD, FAAD, talks with Shawn
The doctor will see you...soon?
Facts at your Fingertips ... By Emily Margosian, assistant editor, July 1, 2019 As efforts to improve access to dermatologic care remain ongoing (Read ... Dermatology World ’s 2017 feature "Access Granted" at ... www.aad.org/dw/monthly/2017/october/access-granted for strategies to broaden patient access), how long can the average patient expect to wait
The congenital perineal groove: Defective recognition of a dermal defect
By Warren R. Heymann, MD ... Feb. 28, 2018 ... It has been nearly half a century since Stephens first detailed the perineal groove (PG) as a congenital malformation consisting of three features: (1) a wet groove in the midperineum between the fourchette and the anus; (2) normal formation of
MUE, MAI, and you
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, June 3, 2019 Test your knowledge: MUE, MAI, and you ... Take the quiz to see if you're up
Is there a genetic basis of CCCA and, if so what is it?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, July 1, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Amy McMichael, MD, about her
Monitoring infantile hemangiomas: What’s the score?
By Howard B. Pride, MD, FAAD Geisinger Medical Center, Department of Dermatology Aug. 11, 2021 Vol. 3, No. 32 Infantile hemangiomas (IH) are common vascular tumors that generally run a self-limited course of rapid growth in the first 2-3 months of life, slow growth for another 4-6 months, and then
Mohs Surgery Appropriate Use Criteria (AUC) app
There are many considerations when determining whether to use Mohs surgery for the treatment of skin cancer, such as the cancer type, location, and whether it is new or recurring, as well as the health profile of the patient. ... With the Academy's complimentary Mohs Surgery Appropriate Use Criteria (AUC)
Of strife and SDRIFE
By Warren R. Heymann, MD May 17, 2017 Patient 3. SDRIFE. Frontal view (A) and right lateral view (B) with erythema and blanching papules coalescing into plaques with vesicles on back, abdomen, and bilateral inframammary and inguinal folds. ... Credit: ... JAAD A conceivable Yelp review: I was so uncomfortable
For patients with erythropoietic protoporphyria the tide has come in
By Warren Heymann, MD May 12, 2021 Vol. 3, No. 19 Oct. 8, 2019, was an eventful day for patients with erythopoietic protoporphyria (EPP) in the United States, when the FDA announced its approval of afamelanotide (Scenesse). (1) The drug was first approved in Italy in 2010. (2) ... Patients
November 18, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / November 18, 2020 ... Hydrogen peroxide and the common wart: Phase 2 results are in DermWorld Insights and Inquiries : Granulomatous slack skin — More than one type of mimicry FDA
New data to recall when considering radiation recall dermatitis
By Warren R. Heymann, MD Sept. 30, 2020 Vol. 2, No. 39 I have always been mystified by the diagnosis of radiation recall dermatitis (RRD). RRD was first described in 1959 by D’Angio et al who stated: "Actinomycin D therapy alone can reactivate ‘latent’ radiation effects in normal tissues. For
Speculating on spicules: Our incomplete knowledge of trichodysplasia spinulosa
By Warren R. Heymann, MD, FAAD December 15, 2021 Vol. 3, No. 49 For inexplicable reasons, there are certain differential diagnoses that I find particularly satisfying, one being disorders responsible for facial follicular spicules: follicular mucinosis (1), pityriasis folliculorum ... (Demodex folliculorum) (2), follicular hyperkeratotic spicules (myeloma immunoglobulin or cryoglobulin)
Private payer appeal letter tool
How can I appeal insurance denials? ... Use the tool below to generate letters from automated templates. These letter templates are intended to help dermatologists appeal to private payers when payments are inappropriately reduced. They may be modified to specifically address your circumstances and those of your patients. ... {{
Ransomware attacks on U.S. health care double
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, February 1, 2024 Ransomware is on the rise. A recent ... JAMA Health Forum study found that the annual number of ransomware attacks on health care organizations more than doubled from 2016 to 2021, exposing the personal health information (PHI)
Melanoma incidence rising, deaths decreasing
Facts at your fingertips ... By Emily Margosian, assistant editor, December 1, 2019 According to data from the National Institutes of Health (NIH) Surveillance, Epidemiology, and End Results Program (SEER), there were an estimated 96,480 new cases of melanoma of the skin in 2019 — making it the fifth most
Demand for cosmetic procedures resumes after COVID
Facts at your Fingertips ... By Emily Margosian, Assistant Editor, April 1, 2023 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions due to the ebb and flow in national and regional caseloads. ... The release of new
Itching to see if polymerase chain reaction mite be the future of diagnosing scabies
By Warren R. Heymann, MD January 6, 2021 Vol. 3, No. 1 The scourge of scabies has been plaguing mankind for millennia. The causal relationship of the itch mite causing scabies was discovered by Bonomo and Cestoni in 1687, earning the distinction of being the first to discover a proven
COVID’s impact on cosmetic procedures
Facts at your fingertips ... By Emily Margosian, Assistant Editor, April 1, 2022 During the start of the COVID-19 pandemic, many practices paused elective and cosmetic procedures for several weeks, followed by further disruptions throughout the year due to the ebb and flow in national and regional caseloads. The release
January 30
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / January 30, 2019 ... Dermatologists prescribe fewer antibiotics overall, but use increased with surgery CMS updates Open Payments data What causes allergic responses in patients with atopic dermatitis? YouTube videos about
Seeing red with dupilumab
By Warren R. Heymann, MD, FAAD March 1, 2023 Vol. 5, No. 9 Since its release in 2017, dupilumab (a fully humanized monoclonal antibody that blocks IL-4 and IL-13) has transformed the therapeutic landscape for managing atopic dermatitis (AD) and other eczematous disorders, bullous pemphigoid, Kimura disease, etc. when used
Paradoxical biological reactions and Grandma Dora’s waterbed
By Warren R. Heymann, MD January 22, 2020 Vol. 2, No. 3 My late maternal grandmother Dora — a real ... balabusta (Yiddish for "mistress of the house") — was the first person I knew to get a waterbed. That raised eyebrows, until I explained that it comforted her octogenarian
Topical amelioration of neuropathic pain and pruritus leading to painful consequences
By Warren R. Heymann, MD Dec. 26, 2016 Increasingly, compounded amitriptyline and ketamine have been utilized for the management of neuropathic pain and pruritus. A review of PubMed reveals its utility in erythomelalgia and diverse neuropathic disorders (peripheral neuropathy, radiation-induced neuropathy, chemotherapy-induced neuropathy, post-herpetic neuralgia, proctodynia, and pain associated with
2023 MIPS and telehealth highlights
Eligibility criteria ... The low volume threshold remains the same as 2022 and includes 3 aspects of covered professional services: ... Allowed charges ... Number of Medicare patients who receive services ... Number of services provided ... You must participate in MIPS (unless otherwise exempt) if, in both 12-month segments of
Angiosarcomas and morbid obesity: An enormous problem
By Warren R. Heymann, MD Feb. 26, 2017 Localized lymphedema. A, Case 7 showed many polypoid lesions that varied in size and were localized throughout the vulva, pubis, and perineum. B, Case 9 showed multiple small polypoid lesions with cauliflower-like morphology in the penis and scrotum. C, Case 3 showed
Netherton syndrome: From apex to nether
By Warren R. Heymann, MD March 31, 2021 Vol. 3, No. 13 If you are a dermatologist preparing for your board exam, I’ll wager that you can rattle off the classical features of Netherton syndrome (NS, aka Comel-Netherton syndrome) in a heartbeat. The more important question — would you recognize
AAD membership at a glance
Facts at your Fingertips ... By Emily Margosian, content specialist, June 1, 2018 Which way are the winds of dermatology blowing? AAD membership data may serve as a bellwether. In 2018, overall membership surpassed 20,000 dermatologists, but beyond hitting the 20K mark, other demographic changes regarding gender and practice type
What are the updated guidelines of care for the management of primary cutaneous melanoma?
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, December 3, 2018 In this month’s Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Susan M. Swetter, MD, and
Reporting excimer laser therapy: When to use 96999 vs 9692x
As a result of a code descriptor change for CPT codes 96920-96922 effective Jan. 1, 2024, these codes are now to be used only for excimer laser treatment of psoriasis. This change was made by the AMA CPT to better align with the intended use of these services exclusively for
DermWorld Weekly comparing efficacy of JAK inhibitors used in alopecia areata
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 22, 2023 ... Comparing efficacy of JAK inhibitors used in alopecia areata DermWorld Insights and Inquiries : Resorcinol’s resourcefulness in hidradenitis suppurativa Derm Coding Consult : CMS Targeted Probe and
A presidential viewpoint: “Nobody knew that benign vascular lesions of the lip could be so complicated”
By Warren R. Heymann, MD April 14, 2017 Well, maybe not as befuddling as replacing Obamacare, but there may be occasional difficulties in diagnosing benign vascular lesions of the lip, with implications for appropriate therapy. ... Tobouti et al, in a study from an oral pathology service, found that of
Melanoma fact sheet | AAD
Q. What is melanoma? A. Melanoma, the most serious form of skin cancer, is characterized by the uncontrolled growth of pigment-producing cells. Melanoma may appear on the skin suddenly without warning but also can develop within an existing mole. The overall incidence of melanoma continues to rise. (1,2) ... Q.
Eosinophilic pustular folliculitis: Six decades of progress
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, March 1, 2026 Vol. 8, No. 3 Eosinophilic pustular folliculitis (EPF) is a quizzical disorder. In 1965, Ise and Ofuji described the case of a 42-year-old woman who "repeatedly developed crops of small pustules on the face, the trunk,
Vitiligo, autoimmunity, and cancer?
By Warren R. Heymann, MD May 3, 2017 Disorders associated with autoimmune thyroid disease: systemic lupus erythematosus (A), progressive systemic sclerosis (B), bullous pemphigoid (C), pemphigus vulgaris (D), urticaria (E), and vitiligo (F). ... Credit: ... JAAD While attending the pre-AAD pediatric dermatology seminar in Orlando, I received a call
April 27, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 27, 2022 ... A novel treatment for molluscum contagiosum? DermWorld Insights and Inquiries : Eye-opening news about oxymetazoline Trends in prescribing spironolactone for acne, HS in adolescents Racial biases in
Chanarin-Dorfman syndrome: Shifting out of neutral
By Warren R. Heymann, MD, FAAD Aug. 27, 2025 Vol. 7, No. 34 In nearly all neutrophil, eosinophil and basophil leukocytes and in the monocytes, several clear vacuoles of varying size were observed in the cytoplasm, which after vital staining…revealed a red colour, i.e. contained a fatty substance. The erythrocytes
Practice types in dermatology
Dermatologists can choose from a diversity of practice types, from independent to group and institutional. Each of these practice types comes with trade-offs between between autonomy and support, benefits and risks. There are also new practice models, meant to improve value and contain costs. Use the AAD resources below to
Key messages in social media about eczema
Key messages ... Eczema refers to a group of conditions that lead to inflamed skin. Signs of inflamed skin include a rash, itchiness, and excessive dryness. (1) ... There are several types of eczema. Atopic dermatitis is the most common type. ... Eczema is a complex condition. Your genes, immune
What's hot?
What's hot ... February 26, 2019 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD ... Isn’t it interesting how some common warts that we treat seem to go away almost instantly but others persist
For better or worse technology is changing medicine.
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, September 3, 2018 When is the last time you looked at a paper map or met with a travel agent to book your next adventure? Advances in technology have
Probing pediatric pigmented purpuras
By Warren R. Heymann, MD, FAAD October 20, 2021 Vol. 3, No. 42 Pigmented purpuric (PP) eruptions are often referred to as "benign" pigmented purpuras. Although that may be true in the medical sense, these dermatoses may be very distressing for patients (or their parents). Angst may be due to
Using trusts to shield assets from potential liability
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, September 3, 2018 Given
2026 MIPS and telehealth highlights
Eligibility criteria ... The low volume threshold remains the same as in 2026 and includes 3 aspects of covered professional services: ... Allowed charges ... Number of Medicare patients who receive services ... Number of services provided ... You must participate in MIPS (unless otherwise exempt) if, in both 12-month
4 cradle cap tips from dermatologists
Tips from board-certified dermatologists ROSEMONT, Ill. (August 18, 2022) — Bringing home a new baby is a joyous time for any parent. For first time parents, bringing home a new baby can unlock a wide range of emotions—from excitement to nervousness. As you adjust to parenthood, you’ll notice that your
Glucose monitors: Not as sweet as they seem
By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial
CBD: Potential or placebo?
Go to AAD Home ... Go to AAD Home ... Menu ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... Potential applications and concerns regarding the use of cannabinoids in dermatology ... By Emily Margosian, assistant editor This recent Mother’s Day holiday, shoppers may have observed
AAD's guidance on resources related to workplace violence
Unfortunately, violence in the workplace has become more common in health care and incidences are slowly rising. Has someone at your dermatology practice ever experienced any type of violence at work? Is your practice equipped or prepared to handle violence, if it were to occur? Dermatologists are not always trained
How to prevent keloid scars
Board-certified dermatologist shares tips to reduce your risk ROSEMONT, Ill. (Dec. 6, 2023) — Keloids are a type of raised scar that can occur after an injury, and over time they can grow much larger than the wound itself. Although keloids are not dangerous to a person’s health, they can
Keeping an eye on melanoma
By Warren R. Heymann, MD April 7, 2021 Vol. 3, No. 14 If your practice bears any resemblance to mine, a significant portion of your schedule is devoted to patients following up because of their history of melanoma. Prior to seeing the patient, our medical assistant runs through a focused
Giving a NOD2 to Yao syndrome
By Warren R. Heymann, MD, FAAD March 5, 2025 Vol. 7, No. 9 The 21 ... st ... century has witnessed an expanding array of systemic autoinflammatory disorders (SAIDs) due to innate immunity dysfunction. SAIDs are characterized by recurrent attacks of fever, cutaneous signs, chest or abdominal pain, lymphadenopathy, vasculopathy,
Intermediate and complex repairs 2020: Part 1
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, October 1, 2019 Test your knowledge: Intermediate and complex repairs 2020 — Part 1 ... Take the quiz to
Preventing payment appeals
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, October 3, 2016 Prior Cracking the Code columns have focused upon common billing errors and appeals strategies. However, a
RAC audits: Target areas
This page has quick tips, facts, and links for you to keep on hand so that you can stay on top of the audit game. ... Where a RAC will catch you ... It goes without saying that you must be careful about many procedures when you’re a physician. However,
Striving for hard facts about water softening in atopic dermatitis
By Warren R. Heymann, MD, FAAD Aug. 18, 2021 Vol. 3, No. 33 With the success of dupilumab in managing atopic dermatitis (AD), and new agents on the horizon (IL-13 inhibitors lebrikizumab and tralokinumab; the IL-31 inhibitor nemolizumab; targeted anti IL-17, IL-22, and TSLP inhibitors; JAK inhibitors; and the PDE4
Skin cancer fact sheet
Incidence rates ... Skin cancer is the most common cancer in the United States. (1-3) ... Current estimates are that one in five Americans will develop skin cancer in their lifetime. (4) ... It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day.
Alleviate the ouch
Experts share best practices and review the latest on safety concerns for anesthesia use in children. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2024 Use of anesthesia can be tricky in adults, but even trickier in children. The use of local or general anesthesia in pediatric dermatology
Maximizing your retirement wealth
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Synder, JD, CLU, December 3, 2018 For
CMS Targeted Probe and Educate (TPE) reviews are now in full swing
What is a Targeted Probe and Educate program? ... A Targeted Probe and Educate (TPE) program is a claim review process utilized by the Medicare Administrative Contractor (MACs) designed to help dermatologists reduce claim and billing denials as well as appeals through "one-on-one" corrective action assistance and is overseen by
Recognizing toxic epidermal necrolysis-like acute cutaneous lupus erythematosus ASAP
By Warren R. Heymann, MD, FAAD November 10, 2021 Vol. 3, No. 45 ASAP, the well-recognized acronym for "as soon as possible," takes on special significance for dermatologists confirming the diagnosis of toxic epidermal necrolysis (TEN). In 2004, Ting et al introduced an alternative definition of the ASAP acronym —
This month’s news from across the specialty
What’s hot ... May 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Jason Lee, MD, FAAD The incidence of melanoma in situ has increased to epidemic proportions, rising 50-fold since 1975. Lentigo maligna is the most
Probing pityriasis rosea in pregnancy
By Warren R. Heymann, MD, FAAD January 19, 2022 Vol. 4, No. 3 I have always been captivated by pityriasis rosea (PR). As a second-year medical student, my late brother Andrew (presumably) developed it. I was clueless when he showed me his rash. He immediately told my father that money
Dermatology resident develops face masks from recycled medical supplies
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... DermWorld Weekly talks with Aditi Sharma, MD, a third-year resident in the department of dermatology at the University of California, Irvine, about how she produced a new type of protective face mask made from recycled
Contract reimbursement review
When deciding whether to sign a contract with a payer, reimbursement is one of the most important considerations. Adequate reimbursement is critical to the viability of your practice. Therefore, be sure to review contract language on reimbursement carefully. ... Aspects of reimbursement are often negotiable, though the extent to which
Assessing the significance of a Long-Developed Habit: The role of LDH in dermatology
By Warren R. Heymann, MD, FAAD July 14, 2021 Vol. 3, No. 28 Upon ordering laboratory tests recently for a patient with cutaneous T cell lymphoma, I included a lactate dehydrogenase (LDH) level, as I have done for decades, without giving it much thought. When I came across an article
What’s up in Down syndrome?
By Warren R. Heymann, MD, FAAD October 13, 2021 Vol. 3, No. 41 Being married to a geneticist has served me well as a dermatologist. Just as dermatologists can instantly diagnose many dermatoses based on pattern recognition, geneticists skilled in dysmorphology can identify many syndromes in a heartbeat. Physicians of
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive
Using gene expression profiling to identify risk of melanoma metastasis
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, June 3, 2019 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Sancy Leachman, MD, PhD, about
Telemedicine: Reimbursement liability patient consent and HIPAA
Legally Speaking ... Robert M. Portman, JD, MPP, is a health care attorney with Powers Pyles Sutter & Verville, in Washington, D.C. ... By Robert M. Portman, JD, MPP, Rebecca Burke, JD, and Christina L. Krysinski, JD, September 3, 2018 This month, we follow up on our May 2018 column
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...
Digital media kit: DermWorld editorial calendar
Download a PDF of the 2026 DermWorld editorial calendar . ... JANUARY ... FEBRUARY ... MARCH ... Preparing derms to use ... GLP-1 RA Coding: Soft tissue excision ... Managing declining morale in health care ... Close: 11/25/25 ... Materials due: 12/3/25 ... Mail date: 1/2/26 ... Update on ...
Protect your ability to practice
Money Matters ... David B. Snyder, JD, CLU ... ® ... , is an attorney, author, and financial advisor at the wealth management firm OJM Group. He covers financial issues for dermatologists in this quarterly ... Dermatology World column. ... By David B. Snyder, JD, CLU, June 3, 2019 For
December 24, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Dec. 24, 2025 ... Warts: Local hyperthermia with hydrogen peroxide DermWorld Insights and Inquiries : Holiday greeting 2025 Academy mourns the passing of Alfred W. Kopf, MD FDA alert flags cosmetic
Literature request form
Please note that fields marked with an asterisk are required to submit the form.The boxes handle more text than their size dictates. Standard service is 3-7 days. You cannot submit the form without a budget code. If you require assistance with this form, contact Charniel McDaniels at x1823. ... If
Double check, pause...and proceed
What dermatologists can learn from quality efforts in surgery ... Feature ... By Emily Margosian, content specialist, October 3, 2016 As the culture of health care and developing regulatory trends continue to move in an increasingly quality-focused direction, dermatologists may soon find themselves under more scrutiny. Wrong-site surgery is one
Clinical information
1. How contagious is measles? ... Measles is a highly contagious virus, much more contagious than the common cold and even more contagious than other outbreaks like smallpox or Ebola. ... 1 ... Measles is potentially transmissible even after brief exposures and at distances up to 30 meters. ... 2
The Term “Dermal Hyperneury” Hits a Nerve
By Warren R. Heymann, MD Dec. 21, 2017 ... A, On hematoxylin-eosin stain, the borders of this nerve bundle are sharply demarcated from the surrounding connective tissue with no associated inflammation or fibrosis. A thin layer of epithelium can be seen encapsulating the intersecting fascicles of nerve fibers. Within the
The woolly culprit: Lanolin revealed as an uncommon cause of dermatitis on normal skin
By Christen Mowad, MD, FAAD Nov. 15, 2023 Vol. 5, No. 46 Excitement surrounding the "Allergen of the Year" may only be truly appreciated by those immersed in the field of contact dermatitis and patch testing, but each year the announcement is met with enthusiasm from the wider dermatology specialty.
Twenty years of imiquimod taking its toll on lentigo maligna — Where are we?
By Warren R. Heymann, MD February 12, 2020 Vol. 2, No. 6 Although Y2K never amounted to much, a solitary case report that year changed the dynamic in treating a vexing problem — melanoma in situ of the lentigo maligna (LM) subtype. Ahmed and Berth Jones reported treating an 88-year
Can oral ivermectin cure pediatric periorificial dermatitis? It mite!
By Warren R. Heymann, MD March 5, 2017 A 13-year-old boy with severe rosacea before (A) and 1 month (B) and 4 months (C) after receiving oral therapy with a single dose of 250 μg/kg ivermectin (case 3). Note the facial desquamation after the first weeks of therapy, not attributable
August 28
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 28, 2019 ... Dupilumab shows positive results for younger atopic dermatitis patients DW Insights and Inquiries : Finding joy in pediatric phototherapy FDA, UMD seek feedback on compounded drug use
Granulomatous slack skin: More than one type of mimicry
By Warren R. Heymann, MD November 18, 2020 Vol. 2, No. 46 My chief resident presented a case to me enamored with his clinical diagnosis of granulomatous slack skin (GSS). Although I was delighted that he considered the disorder, I explained why I thought these inguinal and submammary pink-white subtly
Playing the field: Introducing tirbanibulin for actinic keratosis therapy
By Warren R. Heymann, MD January 27, 2021 Vol. 3, No. 4 Field therapy is a cornerstone of actinic keratosis (AK) management. Two years ago, a ... New England Journal of Medicine article demonstrated that 5-fluorouracil (5-FU) was the best among inadequate therapies (compared to imiquimod, MAL-PDT, and ingenol mebutate).
2021 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... Dec. 29 - 2021: Best of DermWorld Insights and Inquiries Dec. 22 - DWI&I Holiday Greeting 2021 Dec. 15 - Speculating on spicules: Our incomplete knowledge of trichodysplasia spinulosa Dec. 8 - Propranolol and neutrophilic dermatoses: Can
Selectivity and the choice of beta-blockers for infantile hemangiomas
By Warren R. Heymann, MD Sept. 11, 2017 Clinical evolution of an infantile ulcerated hemangioma on upper lip of patient 7. Clinical appearance: Before starting propranolol (A); after 12 months of follow-up (3 months of treatment) (B). ... Credit: ... JAAD Has there ever been a more radical change in
Biopsy coding in 2019: Part 2
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, December 3, 2018 Test your knowledge: Biopsy coding in 2019 — Part 2 ... Take the quiz to see
How do I claim CME credits from the Annual Meeting?
Asked and Answered ... May 1, 2019 Your CME credits are just a few clicks away! ... To claim AAD meeting credits: ... Visit www.aad.org/evals , or select the CME/Evals icon on the AAD meeting app. If you do not have your registration code, email aadcme@aad.org . To begin claiming
Leishmania episode 1a: attack of the clones
By Kiran Motaparthi, MD February 10, 2021 Vol. 3, No. 6 Cutaneous leishmaniasis (CL), although not life-threatening, can progress to a disfiguring disease with prominent scarring. Humans serve as reservoirs for > 20 species of ... Leishmania, which are transmitted as flagellate promastigotes by sandflies. Within humans, the organisms convert
May 11, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 11, 2022 ... Sexual dysfunction associated with finasteride use in men with androgenetic alopecia DermWorld Insights and Inquiries : Lagging ahead — LAG-3 checkpoint inhibition for advanced melanoma FDA grants
February 14
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / FEBRUARY 14, 2018 ... A win for dermatology: Congress repeals IPAB, misvalued codes policy Vote in the AAD election by March 3 Are machines poised to replace physicians? Countdown to official
Progress in pemphigus: Solidifying rituximab’s role
By Warren R. Heymann, MD, FAAD July 7, 2021 Vol. 3, No. 27 "Now what do I do?" ... That question, asked by dermatologists every day about patients who are not responding to therapy, was posed in the preface of the first (and every subsequent) edition of ... Treatment of
A future therapeutic Harlequin Romance?
By Warren R. Heymann, MD Sept. 17, 2018 A neonate with harlequin ichthyosis on day 21 of life after 3 weeks of treatment with acitretin at 1 mg/kg/d. ... Credit: ... JAAD My fiancé Ronnie, then a pediatric resident, called me excitedly, asking for my opinion about a remarkable neonate
Short duration cyclosporine may undress DRESS
By Warren R. Heymann, MD July 22, 2016 DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) is a severe drug-induced hypersensitivity syndrome (DIHS) that may affect adults and children. The eruption of DRESS usually appears 3 weeks to 2 months after introduction of the drug. The rash is primarily morbilliform,
Generalized multinucleate cell angiohistiocytomas and thoughts on diagnostic first impressions
By Warren R. Heymann, MD April 1, 2017 I became aware of multinucleate cell angiohistiocytomas (MCA) when I learned of an article published by friends who reported the first cases in the United States (1). The following abstract by Smolle et al (2) accurately described the entity, and my concept
Following up on “A Trend I Cannot Endorse”
By Warren R. Heymann, MD, FAAD Sept. 22, 2021 Vol. 3, No. 38 I admit defeat. ... For those of you who did not read " ... A Trend I Cannot Endorse ," which was published on Dermatology Insights and Inquiries (the forerunner of Dermatology World Insights and Inquiries), please
Autoimmune blistering diseases associated with renal disease: With some hesitancy, reports are beginning to flow
By Warren R. Heymann, MD Sept. 12, 2018 Cryoglobulinemic glomerulonephritis. Patient 3: kidney biopsy found membranoproliferative glomerulonephritis with cryoglobin plugs/hyaline thrombi (arrows), suggestive of cryoglobulinemic glomerulonephritis. (Hematoxylin-eosin stain; original magnification: ×60.) ... Credit: ... JAAD Admittedly, other than monitoring blistering disease patients treated with systemic immunosuppressants, I have not thought
Develop a nose for suspecting angiosarcoma
Angiosarcoma histopathology. Anastomosing dilated vessels, lined by crowded endothelial cells, extend between pre-existing collagen bundles. (Hematoxylin-eosin-saffron stain; original magnification: ×40.) ... Credit: ... JAAD By Warren R. Heymann, MD Nov. 12, 2018 Occasionally I read an article that disturbs me, because I know that I would miss the diagnosis, with
Primary sclerosing cholangitis associated with pyostomatitis vegetans and pyodermatitis vegetans: A potentially bilious situation
By Warren R. Heymann, MD Aug. 29, 2016 Inflammatory bowel disease may be associated with multiple cutaneous manifestations including pyoderma gangrenosum (PG), erythema nodosum, or directly by fistulae or "metastatic" Crohn disease. Seven cases of pyostomatitis vegetans-pyodermatitis vegetans (PSV-PDV) were reviewed. All 7 patients had inflammatory bowel disease (IBD) —
June 7, 2023
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / June 7, 2023 ... Treatments for pseudofolliculitis barbae DermWorld Insights and Inquiries : Taking it on the shin – part two Efficacy of abrocitinib for the treatment of lichen sclerosus? Scientists
Becoming whipped up over flagellate dermatoses
By Warren R. Heymann, MD ... July 13, 2017 ... A, A 44-year-old male patient with characteristic flagellate dermatitis after ingestion of shiitake. B, Same patient 4 days after balneo PUVA therapy. ... Credit: ... JAAD The literature on flagellate dermatoses has been whipped into frenzy. The initial description
Vitamin C as treatment of basal cell carcinoma: Is it fruitful?
By Warren R. Heymann, MD ... July 3, 2016 ... For those of us who learned that taking mega dose vitamin C for the common cold, as advocated by the late Nobel Laureate Linus Pauling, was truly something to sneeze at, I always approach studies lauding the effects of nutrient-based
A point to make about punctate, pigmented, and verrucous papillomatosis
By Warren R. Heymann, MD July 25, 2016 What is your mental image of the Gougerot-Carteaud (GC) syndrome? I equate it with confluent and reticulated papillomatosis, presenting on the trunk with hyperpigmented minimally raised plaques. The KOH examination is negative and there is a quick, characteristic response to antibiotics such
Changing perceptions of pediatric mastocytosis
By Warren R. Heymann, MD Sept. 3, 2018 I have always been disquieted by mastocytosis. Its constellation of clinical presentations from childhood to adulthood, spectrum of systemic involvement, variable prognoses, and therapeutic challenges, never allow for complacency or certainty. ... Even when the diagnosis is straightforward with an excellent prognosis,
A cold abscess remains a cold case: Multiple neonatal staphylococcal cold abscesses of the large folds
By Warren R. Heymann, MD, FAAD Jan. 17, 2024 Vol. 6, No. 3 Graduating residents will usually ask me for parting words of wisdom. If I had to choose one morsel of advice, it would be to read and study throughout their career. I still marvel at reports of entities
Granular detail on granular parakeratosis
By Warren R. Heymann, MD, FAAD October 6, 2021 Vol. 3, No. 40 After attending a clinic at the University of Pennsylvania 30 years ago, I recall relaxing in the cafeteria, coffee in one hand and ... JAAD in the other, being impressed with an article by Northcutt et al
Board of Directors meeting minutes
Below are the approved minutes from the AAD and AAD Association Board of Directors meetings for the past year. Please email Kim N. Andersen, DipESG, at ... knoelleandersen@aad.org with any questions or if you would like to request the minutes from a particular past Board meeting. ... Board of Directors
Not aging like fine wine: The myths and mysteries of acquired port wine stains
By Warren R. Heymann, MD January 13, 2021 Vol. 3, No. 2 Port wine stains (PWS, aka nevus flammeus, nevus simplex, salmon patch) are cutaneous capillary malformations that are characteristically congenital (CPWS) but may be acquired (APWS). APWS was first described in a German publication by Fegeler in 1949, hence
October 30, 2024
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 30, 2024 ... Breast health outcomes in women on oral 5-alpha reductase inhibitors D ermWorld Insights and Inquiries : The breathless complications of anti-MDA-5-positive dermatomyositis What symptoms are most significantly
Up in the air
Go to AAD Home ... Go to AAD Home ... Menu ... With the country embroiled in a public health crisis, how much will the 2020 elections inform health care policy? ... With the country embroiled in a public health crisis, how much will the 2020 elections inform health care
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
Alarming but benign: The enigma of acute hemorrhagic edema of infancy
By Warren R. Heymann, MD, FAAD Sept. 8, 2021 Vol. 3, No. 36 "The patient, a fat baby thriving on its mother’s milk, was suddenly attacked by purpura, urticaria and localized edema, lasting about ten days. There were only systemic symptoms from the result of pain. At first the bowels
The pressure to prevent pressure ulcers
By Warren R. Heymann, MD, FAAD Aug. 24, 2022 Vol. 4, No. 34 Pressure ulcers (PUs, aka decubitus ulcers, pressure sores, bed sores) are due to prolonged pressure, characteristically over bony prominences such as the sacrum, occiput, ischial tuberosities, greater trochanters, heels, and lateral malleoli. (1,2) Interestingly, in the COVID-19
2025 DW Insights and Inquiries archive
Explore ... DermWorld Insights and Inquiries articles by publication date. ... December ... Dec. 24 - DWI&I Holiday greeting 2025 Dec. 17 - Long COVID has a lot of nerve Dec. 10 - The illusions of IgG4-related skin disease Dec. 3 - Pityriasis rosea and pityriasis rosea-like eruptions: A Christmas
Happy 4th of July from DI&I
By Warren R. Heymann, MD July 3, 2018 George Washington contracted smallpox when he was 19 years old. Although he nearly succumbed to the disease, he survived with pockmark scars and life-long immunity. (1) He and other founders recognized the severity of smallpox and its threat to their independence and
One less headache to worry about: Using Isotretinoin in patients with a history of pseudotumor cerebri
By Warren R. Heymann, MD May 13, 2016 I have been prescribing isotretinoin since it was first introduced over thirty years ago, having encountered just a few patients with truly suspect pseudotumor cerebri (PTC). This was manifested by severe headaches and papilledema on ophthalmologic examination. Considering discretion the better part
Evaluation and management: Selecting the codes
Cracking the Code ... Dr. Miller, who is in private practice in Yorba Linda, California, represents the American Academy of Dermatology on the AMA-CPT Advisory Committee. ... By Alexander Miller, MD, September 3, 2018 You have evaluated a patient, and now it is time to select an appropriate level of
Sun safety
Key messages ... At least one in five Americans will develop skin cancer during their lifetime. (1,2) ... Sun exposure is the most preventable risk factor for skin cancer, including melanoma, the deadliest form of skin cancer. (3-6) ... To protect your skin from the sun, seek shade, wear protective
Vitiligo and melanoma: New thoughts on an old observation
By Warren R. Heymann, MD Nov. 27, 2016 I was fortunate that as a resident and fellow I had marvelous attending physicians who would offer their pearls of wisdom. As it is impossible to study every dictum, I would (usually) accept these viewpoints as "facts" and incorporate them into practice.
Future shock of teledermatology
By Warren R. Heymann, MD April 16, 2016 The authors surveyed 62 patients older than 18 years, and 43 caregivers of patients younger than 18 who had been taking isotretinoin for at least 3 months. "Most respondents reported no concern about the safety of an e-visit compared with that of
Changing a long-standing habit
By Warren R. Heymann, MD April 16, 2016 Topical corticosteroid has no influence has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratosis (AK): A randomized clinical trial. ... This is a randomized controlled clinical trial of patients with multiple AK and
I'm confused about the new biopsy codes. Does the Academy offer any resources to help?
Asked and Answered ... June 3, 2019 Absolutely. ... The Academy recently published an update to the online ... Practice Management Center featuring: ... Quick guides Downloadable reference tools Interactive quizzes Need help now? ... Use these tip sheets for practical guidance on common coding: ... www.aad.org/practicecenter/coding-and-reimbursement/coding-resource-center/coding-tip-sheets . ... Still
Dermatology practice staff by the numbers
Facts at your Fingertips ... By Emily Margosian, July 2, 2018 Nurses, aestheticians, billers — who’s most likely to be spotted working in the average dermatology practice? Aside from dermatologists, medical assistants and practice administrators are the most widely employed across all practice settings, according the 2017 AAD Practice Profile
Alopecia areata incognita in Cronkhite-Canada syndrome suggests an autoimmune etiology – and that’s the way it is.
By Warren R. Heymann, MD Sept. 14, 2017 Cronkhite–Canada syndrome. A, Onycholysis. B, Alopecia. ... Credit: ... JAAD I have always been intrigued by the mysterious nature of the Cronkhite-Canada syndrome (CCS) — although I have considered the disorder in my differential diagnosis, I have never seen a case. ...
Oy, another “Oid” to worry about: Cryptococcoid lesions
By Warren R. Heymann, MD July 3, 2019 Vol. 1, No. 17 The suffix "oid" m ... eans "resembling." There is a plethora of "oids" in dermatology — lichenoid, Pagetoid, rupioid, targetoid, to name a few. (My favorite is "oid-oid" disease, aka Sulzberger-Garbe disease, or exudative discoid and lichenoid chronic
Nailing down the treatment for ungual melanoma in situ
By Adam Rubin, MD April 21, 2021 Vol. 3, No. 16 In the recent ... Dermatologic Surgery manuscript "Nail Unit Melanoma In Situ Treated with Mohs Micrographic Surgery" (1), Dr. Divya Srivastava and her colleagues at the University of Texas Southwestern Medical Center demonstrated the effectiveness of the combination of
Nanotechnology for topical cyclosporine: Not a small matter
By Warren R. Heymann, MD July 19, 2016 Taken at face value, the study by Kumar et al, demonstrating the efficacy of topical cyclosporine for psoriasis, utilizing liposomal nanocarriers (lipogel), might elicit a shrug, because in this randomized study, at 14 weeks, complete clearance of psoriasis was observed in 41%
May 18, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 18, 2022 ... Abrocitinib efficacy after switching from dupilumab DermWorld Insights and Inquiries : Coming to grips with lymphocytic thrombophilic arteritis DermWorld Young Physician Focus : Protecting dermatologic scope of
How can I get a receipt for payments made to the Academy?
Asked and Answered ... March 1, 2020 For all Academy-related payments — membership dues, past orders, a subscription to ... Dialogues in Dermatology — AAD members can access their receipts as follows: ... 1. Visit ... www.aad.org/members 2. Sign in to your member profile ... 3. Click the "Account" tab
How can I use DataDerm to report for MIPS?
Asked and Answered ... November 29, 2018 DataDerm™ can help you report for all three MIPS categories in 2018: ... Quality Promoting interoperability (PI) Improvement activities (IA) Here’s how to get started: ... 1. Step one: Sign up. ... Complete the sign-up portal at ... https://dataderm.aad.org/signup/Login.aspx by ... Dec. 7,
Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: The aftermath
By Warren Heymann, MD May 26, 2021 Vol. 3, No. 21 The American Academy of Dermatology’s SkinSerious ... ® ... campaign highlights how dermatologists treat serious diseases. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) top the list. (1) Justifiably, all attention focuses on the immediate issues in an attempt
Injecting ideas (and therapies) in digital mucous cysts
By Warren R. Heymann, MD, FAAD Oct. 8, 2025 Vol. 7, No. 40 I am almost embarrassed to admit it, but I go on clinical autopilot when it comes to digital mucous (myxoid) cysts (DMCs). I offer a brief explanation, reassure the patient that the lesion is benign, refer the
Biting my nails worrying about atypical presentations of nail unit melanomas
By Warren R. Heymann, MD March 27, 2019 Vol. 1, No. 3 I recently encountered a patient who expressed his disappointment in me, complaining that I was too slow to diagnose a lentigo maligna in a facial solar lentigo that we had been following. How could I miss a melanoma?
PASI 100 and the perfection paradox
By Warren R. Heymann, MD June 27, 2016 I am not a psychiatrist, but over the years I have concluded that my patients’ happiness is more supratentorial than epidermal. ... As we approach perfection, imperfections take on far greater importance. Some examples: ... In medical school, I spent many Sunday
Positively perplexing: Determining the meaning of CD30 positivity
By Warren R. Heymann, MD, FAAD Sept. 29, 2021 Vol. 3, No. 39 I’ll wager that most readers of DWI&I have experienced receiving a biopsy report, obtained from an inflammatory lesion, stating "scattered CD30+ cells were observed," accompanied by a comment that "clinicopathologic correlation is necessary to rule out the
Malignant syphilis: History in the making
By Warren R. Heymann, MD, FAAD Jan. 3, 2024 Vol. 6, No. 1 As our new academic year commences, soon I will remind our new residents of Sir William Osler's famous aphorism, "He who knows syphilis knows medicine." As the great mimicker, our trainees will never go astray by including
Digging deeper into lupus erythematosus panniculitis
By Warren Heymann, MD May 5, 2021 Vol. 3, No. 18 Lupus erythematosus panniculitis (aka lupus erythematosus profundus, LEP) has a storied history. The famed clinician Harry Arnold noted that Kaposi (when he was Kohn) observed nodules in patients with lupus. (1) Debates and controversies ensued for decades, with many
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was
Should benign cephalic histiocytosis be renamed? Let’s keep our heads about this decision.
By Warren R. Heymann, MD Sept. 4, 2017 Benign cephalic histiocytosis (BCH) is a rare non-Langerhans cell histiocytic disorder first recognized by Gianotti 46 years ago. (1) Over the years, I have seen several cases of both Langerhans cell histiocytosis (LCH), and non-Langerhans cell histiocytoses, but do not recall ever
Concierge medicine
Concierge medicine involves patients paying a monthly or annual fee for enhanced services. According to Medscape's Compensation Report from 2017, about 3% of dermatologists participate in a concierge model of care. There are many different ways to structure your practice into this model. You can choose to have patients pay
The case for comprehensive patch testing
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, September 3, 2018 In this month’s Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jenny E. Murase, MD, about
Treatments for renal IgA vasculitis are beginning to flow
By Warren R. Heymann, MD, FAAD Feb. 19, 2025 Vol. 7, No. 7 The alliterative phrase "palpable purpura" will instantly conjure the diagnosis of leukocytoclastic vasculitis (LCV) for dermatologists. IgA vasculitis (IgAV, aka Henoch-Schönlein purpura [HSP]) is the most common vasculitis in children but is much less frequent in adults.
Trichobacteriosis: A salute to the Shelleys
By Warren R. Heymann, MD, FAAD Sept. 3, 2025 Vol. 7, No. 35 Indelible memories form in youth. I couldn’t wait to get my New York driver’s license — within a year of that milestone the 1973 oil embargo hit, and most drives were limited to the gas station to
Is ivermectin an old drug with new tricks?
By Temitayo Ogunleye, MD, FAAD Sept. 15, 2021 Vol. 3, No. 37 Most of us are familiar with the use of oral ivermectin in the setting of treating extensive or resistant scabetic or lice infestations, or more rarely (in the United States but very commonly globally) for conditions such as
Become a Corporate Partner of the AAD
Partner with the trusted voice in dermatology ... With a membership of more than 20,500 physicians worldwide, the AAD is the largest, most influential, and representative dermatology group in the United States. Founded in 1938, the AAD is a 501(c)3 nonprofit organization dedicated to promoting leadership in dermatology and excellence
Advocacy Update Apr. 8, 2025
IN THIS ISSUE / Apr. 8, 2025 AADA asks FDA to continue collaboration on AI-enabled medical devices guidance New Jersey expands children’s access to sunscreen Support the second-largest physician PAC and federal dermatology champions Regulatory Affairs AADA asks FDA to continue collaboration on AI-enabled medical devices guidance ... On April
Mpox: Caring for skin
The mpox (monkeypox) virus causes lesions to form on the body. While these can be located anywhere, many individuals during the current outbreak have experienced lesions in the anogenital region, though involvement of other areas including the face, extremities, and mucosal areas such as the mouth have also occurred. ...
Taking the challenge: Social media, adolescents, and the skin
By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the
Office staff guide
This guide is meant for staff scheduling teledermatology visits. If the requirements below can’t be satisfied, consider offering an in-person visit. ... Is teledermatology appropriate for the specific patient need? ... Has the patient participated in teledermatology with your office before? ... If yes, schedule the teledermatology visit and remind
April 28, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / April 28, 2021 ... Acne: Clindamycin-tretinoin vs. benzoyl peroxide-adapalene DermWorld Insights and Inquiries: Do not get burned by missing Staphylococcal scalded skin syndrome Is daylight photodynamic therapy effective for actinic keratosis?
Dermatology and dermatopathology awake: now is the time to embrace the artificial intelligence revolution
By Jason B. Lee, MD June 23, 2021 Vol. 3, No. 25 In 1991, the late Dr. A. Bernard Ackerman sounded the alarm about the decline in the interest in dermatopathology by dermatologists in an effort to preserve this foundational subspecialty within dermatology. (1) Although not with the same urgency,
December
Issue ... December January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... 2021 What's hot ... This month's news from across the specialty Feature ... COVID-19 and dermatology What have we learned about the cutaneous manifestations
AAD bolsters information about darker skin tones
New and updated content on AAD.org reflects our commitment to providing information for patients of all skin tones. ... The Academy launched a ... Darker Skin Tones resource center in 2022, which included updates on 11 conditions that affect people with darker skin tones more frequently or more severely. It
July 16, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 16, 2025 ... Female pattern hair loss: Is systemic minoxidil effective over the long term? DermWorld Insights and Inquiries : Pathway to clarity — The new and improved Melanocytic Pathology
Immediate pathology report release to patients – Is the 21st Century CURES Act worse than the disease?
By Lorraine L. Rosamilia, MD, FAAD Staff Dermatologist, Geisinger Health System Aug. 25, 2021 Vol. 3, No. 34 The 21st Century Cures Act, signed into federal law in 2016, was enacted to optimize medical product development and advance patient access to medical innovations. Notable for inclusion of patient perspectives in
Like the tumor itself, knowledge about DFSP is expanding wider and deeper
By Warren Heymann, MD June 16, 2021 Vol. 3, No. 24 Dermatofibosarcoma (DFSP) is a mystifying lesion. Although considered rare, I have encountered several cases over the years. Some recent literature offers potential insights into its pathogenesis and management. ... DFSP is a low-to-intermediate grade sarcoma with a reported incidence
January
Issue ... January January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... From the editor Asked and Answered ... I am on the OLC. Where can I find the JAAD and Dialogues in Dermatology quizzes? What's
Honing in on diffuse dermal angiomatosis
By Warren R. Heymann, MD February 17, 2021 Vol. 3, No. 7 Diffuse dermal angiomatosis (DDA) was conceptualized as a variant of reactive angioendothelimatosis (RA) in 1994 by Krell et al, reporting on two women, both with severe peripheral vascular disease requiring bypass grafts, presenting with ulcerated, violaceous plaques on
Advocacy Update Jan. 14 2025
IN THIS ISSUE / Jan. 14, 2025 2025 Congressional key dates Add your voice: Become an AADA Key Contact SkinPAC reception at Orlando Annual Meeting Congressional activity 2025 Congressional key dates ... On Jan. 3, the 119th Congress started its new session and commenced with leadership elections in the House.
November
Issue ... November January February March April May June July August September October November December View digital flipbook In this issue ... From the Editor ... It’s always the gluten What's hot ... This month's news from across the specialty Clinical Applications ... How is structural racism affecting atopic dermatitis
AAD | Best Practices for Prior Authorization
Top strategies for prior authorization ... 1. The process of prior authorizations can be painful. Accept that it will take time. ... 2. Assign a dedicated staff member (such as a medical assistant) to handle prior authorization requests, so as a dermatologist, you have more time with patients and more
Despite concerns, dermatologists retain primary control of their practices
Facts at your Fingertips ... By Emily Margosian, assistant editor, June 3, 2019 Amid ongoing debate about the evolution of dermatology practice settings and the role of equity-backing in the specialty, new AAD survey data indicates that dermatologists have maintained both primary ownership and management of their practices. According to
Insult to injury: COVID-19-associated mucormycosis
By Warren Heymann, MD June 9, 2021 Vol. 3, No. 23 As America unmasks this Memorial Day, COVID-19 is ravaging India. The scenes of desperation stemming from the overwhelmed heath system, poverty, and funeral pyres are almost unfathomable. In the midst of the devastation, doctors in India have observed an
February 21
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / FEBRUARY 21, 2018 ... CMS releases MIPS quality performance scores Vote in the AAD election by March 3 Study indicates e-consults improve access to dermatology How helpful is federal research funding?
Moving or closing practices? Here's what you need to know.
In Practice ... Faiza Wasif, MPH, is the AAD's practice management manager. Her column offers tips on an area she commonly receives questions about from members. ... By Faiza Wasif, MPH, December 3, 2018 There is a lot you must consider before you move or close your practice including the
Move over Lues: Graft-versus-host disease is the new mimicker king
By Warren R. Heymann, MD May 9, 2016 I have always been intrigued by graft-versus-host disease (GVH). I first learned of the disorder in my college immunology course when it was referred to as a cause of "runting syndrome" in mice. ... In the context of transplant recipients, classical features
Touching on contact pemphigus and pemphigus-like eruptions due to imiquimod
By Warren Heymann, MD June 2, 2021 Vol. 3, No. 22 Most astute medical dermatologists are aware of drug-induced pemphigus, but many (including myself) may not be as familiar with topical medications being the responsible culprits. This commentary will focus on imiquimod-induced pemphigus and pemphigus-like eruptions (PLE). ... My curiosity
Advocacy Update May 5, 2026
IN THIS ISSUE / May 5, 2026 Advocacy win: United Healthcare delays referral program penalties Dr. Gross attends political event on behalf of SkinPAC New Medicare physician payment reform legislative efforts AADA presents at FDA nonprescription drugs access public meeting Payer Advocacy Advocacy win: United Healthcare delays referral program penalties
How can I get involved with this year’s Legislative Conference?
Asked and Answered ... July 1, 2024 The 2024 AADA Legislative Conference will take place Sept. 8-10, at the JW Marriot in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the
Basal cell carcinoma
Basal cell carcinoma (BCC) is the most common human skin cancer, comprising more than half of all non-melanoma skin cancer diagnoses, that affect more than 3 million Americans annually. These evidence-based guidelines for the management of BCC provide the most current information on widely accepted therapies, emerging treatments, staging, biopsy
Advocating for you — We prevented Medicare cuts in 2022
In 2021, the specialty was facing Medicare payment cuts of up to 10% due to the policy changes with the evaluation and management (E/M) codes, sequestration, and the budget rules associated with the Pay-As-You-Go Act of 2010. The AADA focused on averting the steep cuts — looking for long-term solutions
Can topical ketoconazole tip the scales for acne vulgaris?
By Warren R. Heymann, MD Oct. 28, 2020 Vol. 2, No. 43 How often do you perform an oral examination? If you’re like me, probably only under two circumstances — when the patient has specific complaints (soreness, a raised lesion, or a discoloration noted by their dentist), or when we
Fire ant stings: From pain to gain — The therapeutic potential of solenopsin
By Warren R. Heymann, MD, FAAD July 3, 2024 Vol. 6, No. 27 Fire ant stings are nasty. Lesions usually occur on the lower extremities after the disruption of a nest, causing a large number of ants to swarm and attack. The most common presentation is a wheal and flare
Multiple pilomatricomas by the numbers
By Warren R. Heymann, MD February 24, 2021 Vol. 3, No. 8 I have always been beguiled by pilomatricomas (PM). From the time I first heard the term "calcifying epithelioma of Mahlerbe" or pondering "is it pilomaticoma or pilomatrixoma?" this benign lesion has been a source of wonder. There is
Dermatology heads to Capitol Hill
Facts at your Fingertips ... By Emily Margosian, assistant editor, December 3, 2018 The contentious midterm election season has concluded, but the impact from the 2018 AADA Legislative Conference is still going strong. In July, physicians, patients, patient advocates, dermatology nurses, and dermatology practice administrators gathered in Washington, D.C. to
Gaining experience face-to-face
Brittany Valk, DO, was able to attend her very first in-person AAD Annual Meeting. Dr. Valk’s story ... Brittany Valk, DO, PGY-3 at Michigan State University College of Osteopathic Medicine. ... I had the privilege of attending the 2022 AAD Annual Meeting in Boston this past spring. Due to the
Pityriasis rosea and pityriasis rosea-like eruptions: A Christmas tale
By Warren R. Heymann, MD, FAAD Dec. 3, 2025 Vol. 7, No. 47 Santa Claus waving from his sleigh on Central Park West on Black Friday traditionally commenced the Christmas holiday season. That "official" start now occurs after the last trick-or-treater devours their Hershey bar on Halloween. Realistically, it is
Key messages for social media about aging skin
Key messages ... Exposure to ultraviolet radiation from the sun and indoor tanning beds is the most preventable cause of early skin aging. (1-3) ... The most effective ways to prevent wrinkles and sun damage are to protect yourself from the sun by seeking shade, wearing protective clothing and applying
How can I get involved with this year’s Legislative Conference?
Asked and Answered ... July 1, 2023 The 2023 AADA Legislative Conference will take place Sept. 10-12, at the Conrad Hotel, in Washington, D.C. ... Attending the conference is as easy as 1, 2, 3. You can expect: ... Two days of networking and learning from political experts about the
What's hot?
What's hot ... July 24, 2018 In this monthly column, members of the ... Dermatology World Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... The first human retrovirus, identified in 1980, was not HIV, but human T-cell lymphotrophic virus-1 (HTLV-1). It
Putting a finger on the diagnosis of Achenbach syndrome
By Warren R. Heymann, MD, FAAD July 28, 2021 Vol. 3, No. 30 Please study the image below first. Castillo et al reported the case a 48-year-old woman complaining of acute pain, swelling, and ecchymosis of the volar aspect of her right third finger, sparing the fingertip, when walking her
Complications of silicone injections: persistence, stigma, and treatment
By Howa Yeung, MD, MSc, FAAD Jan. 18, 2023 Vol. 5, No. 3 Walking in with a cane and reporting his severe skin pain, a patient of mine recalled travelling with their friend to get buttock injections in a hotel room in another state over a decade ago. ... The
Viva ex vivo dermoscopy?
By Warren R. Heymann, MD March 12, 2017 Evaluation of dermoscopic features on a formalin-fixed specimen (ex vivo dermoscopy) using a smartphone attached to a dermoscope. ... Credit: ... JAAD It has been said that the best "special stain" is a deeper section — wise words indeed. While always gratifying
Congress passes one-year increase to Medicare physician payment in budget bill
July 3, 2025 Advocacy News Alert Today the U.S. House of Representatives passed the Senate’s version of the budget reconciliation legislation, which includes a one-year 2.5% increase for the proposed 2026 Medicare Physician Fee Schedule to account for sustained cuts as Congress continues to work toward long-term payment reform. ...
Practice Management Corner: CMS Released Preliminary 2018 MIPS Participation Data
The Centers for Medicare & Medicaid Services (CMS) Quality Payment Program (QPP) which began in 2017, is in its third performance year. In July 2019, CMS published a blog and released an infographic with preliminary data on the 2018 QPP Merit-based Incentive Payment Program (MIPS) program participation which revealed the
Do not get burned by missing Staphylococcal scalded skin syndrome
By Warren Heymann, MD April 28, 2021 Vol. 3, No. 17 I would be surprised if any first-year dermatology resident could not differentiate Staphylococcal scalded skin syndrome (SSSS) from toxic epidermal necrolysis (TEN). What is straightforward now was a source of confusion for decades. The following is an elegant summation
February 28
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / FEBRUARY 28, 2018 ... Anthem rescinds proposed modifier 25 policy Vote in the AAD election by March 3 FDA grants rituximab priority review for pemphigus vulgaris CMS eases up on value-based
Allopurinol-induced adverse reactions: More than genetics
... By Warren R. Heymann, MD June 25, 2016 There are certain drugs that confer a high risk of severe cutaneous adverse reactions (SCAR) ranging from morbilliform drug eruptions, DRESS, Stevens-Johnson, to Toxic Epidermal Necrolysis. You know the usual suspects — anticonvulsive agents, sulfa drugs, other anti-infective agents, and
Patient guide
This guide is for use by patients before the teledermatology visit. ... Preparing for the visit ... Does your insurance cover live interactive telehealth services and understanding of copays? ... Do you have the required equipment, such as a smartphone, tablet, or computer with a webcam, that will work with
2026 AADA Legislative Conference
Join your peers at the 2026 AADA Legislative Conference and tell Congress to reform Medicare physician payment, the Academy’s sole Federal congressional advocacy priority. ... This activity has been approved for ... AMA PRA Category 1 Credit™ What to expect ... Attending the 2026 AADA Legislative Conference is as easy
Fixating on doxycycline-induced fixed drug eruptions
By Warren R. Heymann, MD, FAAD May 21, 2025 Vol. 7, No. 20 When reading medical journals, I am intrigued by titles that inspire me to learn more about the topic. Happening upon a letter to the editor titled "Doxycycline-induced fixed drug eruption: The new epidemic?" (1) gave me pause.
This month's news from across the specialty
What's hot ... February 1, 2020 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... EDWARD COHEN, MD, MHSc Apremilast, an oral inhibitor of phosphodiesterase 4, was approved in 2014 for the treatment of psoriasis and psoriatic
Deep learning in dermatopathology
By Kiran Motaparthi, MD June 30, 2021 Vol. 3, No. 26 Deep learning algorithms — deep neural networks that model the connections neurons make and analyze images in successive layers to ultimately produce a likelihood of diagnosis — can now distinguish dermoscopic images of nevus and melanoma with greater accuracy
DWI&I Holiday Greeting 2021
By Warren R. Heymann, MD, FAAD December 22, 2021 Vol. 3, No. 50 Dear ... DWI&I devotee: ... The end of the year is a time for reflection and hope. Everyone reading this commentary has been affected by the pandemic. My heart goes out to anyone who has lost a
FAQs - Coding for Intermediate and Complex Repairs in 2020 and beyond
Q: Are there any changes to the Simple Repair guidelines? A: No, the simple repair guidelines will remain unchanged for 2020 and beyond. ... Q: How should I code a nasal tip excision, for which the defect is repaired with a linear layered closure (3 cutaneous and 5 super-ficial sutures)
How to maintain your EHR
Dealing with your EHR can be cumbersome, but follow these tips to optimize your EHR and make your use more efficient. ... 1. Connect leadership and EHR users ... Boosts provider satisfaction long-term and reduces slowdown. ... 2. Enhance hardware and built-environment solutions ... Implement side-by-side seating for physicians, clinical
October 30, 2019
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / October 30, 2019 ... Potential treatment for chronic urticaria may offer complete control DW Insights and Inquiries: Can chowing down improve pseudoxanthoma elasticum? Advances in medical technology: friend or foe? Do
Advocacy Update Feb. 11 2025
IN THIS ISSUE / Feb. 11, 2025 Act now to stop Medicare payment cut AADA urges members to oppose physician assistant independent practice legislation AADA opposes Regence Blue Cross Blue Shield payment reduction Dermatologists demand Aetna cover psoriasis treatment AADA insists CMS retain MA plan measures on appeals Contribute to
Body dysmorphic syndrome
Legally Speaking ... Clifford Warren Lober, MD, JD, presents legal dilemmas in dermatology every other month. He is a dermatologist in practice in Florida and a partner in the law firm Lober, Brown, and Lober. ... By Clifford Warren Lober, MD, JD, December 3, 2018 Lori: Bryan, I recently excised
Advocacy Update Jan 20, 2026
IN THIS ISSUE / Jan. 20, 2026 Dr. Bridges selected for Medicare Clinical Lab Diagnostic Laboratory Test Panel AADA asked CMS to ensure Medicare Part D coverage for alopecia areata treatment Dermatology presence strong at AMA State Advocacy Summit Contribute to SkinPAC AADA News Dr. Bridges selected for Medicare Clinical
Dupilumab: The first year
By Warren R. Heymann, MD ... Jan. 8, 2018 A patient with severe atopic dermatitis has benefited from dupilumab. ... Credit: Warren R Heymann ... When introduced as dermatologist to a new acquaintance, I’m sure you have heard: "Dermatology is a great field — you don’t cure anybody, so
Reflecting on 2018 with gratitude
From the President ... Dr. Olbricht served as Academy president from March 2018 to March 2019. ... By Suzanne Olbricht, MD, December 3, 2018 Legendary crooner Andy Williams may have said it best in his song, "It’s the Most Wonderful Time of the Year." Holidays aside, for me this time
Doing our part to make a difference
From the President ... Dr. Hruza served as Academy president from March 2019 to March 2020. ... By George Hruza, MD, MBA, June 3, 2019 "When you think about yourself, skip the only,’ as in I’m only a surgeon’ or I’m only a dermatologist.’ Think about what needs to be
A medal-worthy diagnosis: Medallion-like dermal dendrocyte hamartoma
By Warren R. Heymann, MD, FAAD Aug. 30, 2023 Vol. 5, No. 35 A personal joy of dermatology is rendering a diagnosis in a lesion or rash that I have only read about but never previously encountered in practice. Beyond being intellectually satisfying, having a precise diagnosis is reassuring, as
New evaluation and management (E/M) coding changes are coming in 2021 – Practical applications of the 2021 E/M coding changes
Selecting the E/M level of service ... Part 3 of the "E/M coding changes are coming in 2021" series will focus on the practical application of the changes to dermatology-specific encounters based on ... medical decision making (MDM) or ... time . (Review ... part 1 and ... part 2
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, December 3, 2018 Christmas came early for dermatology. Indeed, it came early for all of medicine this year when the Centers for Medicare and Medicaid Services (CMS) released its final rule implementing
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, September 3, 2018 I have learned many new things from the past few editors of ... Dermatology World . This edition is no exception. I know much more about microneedling than I
From the editor
From the Editor ... Dr. Schwarzenberger is the former physician editor of ... DermWorld. By Kathryn Schwarzenberger, MD, June 3, 2019 You asked, we listened. We had an outstanding response to our readership survey this year (thanks to all of you who took the time to offer your thoughts and
Hoops and happiness: Having the courage to take a shot
By David A. Wetter, MD March 17, 2021 Vol. 3, No. 11 In dermatology our daily routine is dominated by caring for patients, many of whom have complex diseases that are difficult to manage. Our dedication to help our patients initially drew many of us to the medical profession (and
This month’s news from across the specialty
What’s hot ... November 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MS, MPH, FAAD All medical fields can learn from their past mistakes. The path to modern medical practice was not
Obituaries
Obituaries ... By Jerry Graff, MD, June 3, 2019 The Academy recently learned with sorrow of the passing of the following members of the dermatologic community. ... JON GARRY BEIDLER, MD, of Chambersburg, Pennsylvania, Dec. 30, 2018, at age 82. Trained in dermatology at University of Pennsylvania and practiced in
This month’s news from across the specialty
What’s hot ... July 1, 2025 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Michael A. Marchetti, MD, FAAD Although management options for chronic spontaneous urticaria (CSU) improved with the introduction of the anti-IgE monoclonal antibody omalizumab
Reducing the burden of clinical documentation with EHRs
In Practice ... By Swapna Bhatia, MPH, June 3, 2019 It’s no surprise that clinical and administration documentation burden with electronic health records (EHRs) has been on the rise. ... Although 78% of dermatology practices reported acquiring an EHR system in the 2017 AAD Practice Profile Survey, the Academy recognizes
April 11
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / APRIL 11, 2018 ... How did you fare with MIPS? Take a look. Help wanted: AAD Pruritus Measure Testing Project Indoor tanning bed users not getting screened What is the economic
Documentation and reporting requirements for adjacent tissue transfer or rearrangement
Derm Coding Consult ... By Faith C. M. McNicholas, RHIT, CPC, CPCD, PCS, CDC, Senior Manager, Coding and Reimbursement, June 1, 2025 Academy coding staff address important coding topics each month in DermWorld ... Coding Consult. Read more Derm Coding Consult articles . Adjacent tissue transfer (ATT) or rearrangement procedures
Deep penetrating thoughts about deep penetrating nevi
By Warren R. Heymann, MD Jan. 14, 2019 Histopathological features of deep penetrating nevus (DPN). A, At low power, the punch biopsy specimen demonstrates a well-circumscribed, wedge-shaped, pigmented dermal lesion, tapering toward the subcutaneous fat. B, DPN typically track along adnexal structures and neurovascular bundles, as shown on this high-power
Workplace violence
Legally Speaking ... Clifford Warren Lober, MD, JD, presents legal dilemmas in dermatology every other month. He is a dermatologist in practice in Florida and a partner in the law firm Lober, Brown, and Lober. ... By Clifford Warren Lober, MD, JD, June 3, 2019 Question: What is workplace violence?
Wait no more
In Practice ... By Victoria Houghton, managing editor, September 3, 2018 Dermatology World talks with Benjamin Chong, MD, MSCS service chief of dermatology at Parkland Health and Hospital System in Dallas about how he addressed long wait times. ... Dermatology World: Describe the access issues with the dermatology clinic at
Keeping up
Dermatologists discuss the various methods for staying current with the latest medical research ... Feature ... By Ruth Carol, contributing writer, August 1, 2021 With an estimated 33,000 peer-reviewed, English-language, scientific journals and more than 3 million articles published each year, it’s no wonder that staying current with the medical
August 21
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / August 21, 2019 ... FDA grants breakthrough therapy designation to advanced melanoma treatment DW Insights and Inquiries : Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections Quality
Applying the 2021 E/M coding concepts in everyday practice – Part 3
Part three of the AADA’s clinical vignettes focuses on the application of the more challenging concepts related to the review and analysis of data in the AMA Medical Decision-Making table. Understanding the application of these concepts will assist you in determining when data may impact the level of service provided.
What is the path forward for treating children with severe atopic dermatitis with dupilumab?
Clinical Applications ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, March 1, 2021 In this month’s Clinical Applications column, Physician Editor Kathryn Schwarzenberger, MD, talks with Amy Paller, MD, about her
Propranolol and neutrophilic dermatoses: Can beta-blockade be better blockade?
By Warren R. Heymann, MD, FAAD December 8, 2021 Vol. 3, No. 48 Ask any dermatology resident what the first-line treatment is for infantile hemangiomas (IH) and you will get a matter-of-fact response — "propranolol" — as if this has been an entrenched fact for decades. Barely more than a
Payer advocacy: Prior authorization
The Academy advocates that prior authorization determinations should be standardized, and the speed of determination should be quantified and minimized. Unduly delays and poorly designed prior authorization protocols can cause irreparable harm to patients. ... Notable payer advocacy updates ... CMS issued new regulations on prior authorization that provide important
Digital media kit: E-newsletter rates and specs
Click image to enlarge ... Reach the full AAD membership weekly (of those who haven’t opted out, approximately more than 16,000 globally) with two e-newsletters. ... DermWorld Academy Insider 30.3%* open rate Delivered each Thursday, ... DermWorld Academy Insider includes the Academy’s most popular education content, Question of the Week.
Vascular abnormalities in FFA, artificial intelligence, and Winston Churchill
By Warren R. Heymann, MD, FAAD Aug. 23, 2023 Vol. 5, No. 34 If Winston Churchill were a dermatologist, he would say that frontal fibrosing alopecia (FFA) is "a riddle wrapped in a mystery inside an enigma" (which is how he viewed Russia). Almost 30 years have passed since Kossard
Key messages to communicate about Indoor tanning
Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger
February 16, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Feb. 16, 2022 ... A review of calcipotriol plus 5-fluorouracil for actinic keratosis DermWorld Insights and Inquiries : Vascular Ehlers-Danlos syndrome: From rupture to rapture? Delayed complications for FDA-approved HA dermal
What's hot?
What's hot ... March 27, 2018 In this monthly column, members of ... Dermatology World 's Editorial Advisory Workgroup identify exciting news from across the specialty. ... Edward W. Cowen, MD, MHSc ... Alopecia areata is frustrating to patients, parents, and practitioners, all of whom may be left with unsatisfactory
Hairdressers’ dermatologic odyssey: From dye to death prevention
... By Warren R. Heymann, MD Dec. 18, 2017 My younger daughter Deborah was destined to be a hair stylist. When she was a camper in the Poconos, I received an urgent call from the staff about her. Assuming the worst, my heart palpitating in fear, all I could
Advocacy Update Feb. 4 2025
IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC
Stepping back from the abyss: A kinder, gentler variant of calciphylaxis
By Warren R. Heymann, MD March 16, 2017 My reaction to the diagnosis of calciphylaxis is Pavlovian — I automatically think about an end-stage renal insufficiency patient with an abysmal prognosis. Increasingly there are reports of nonuremic forms of the disease, where the prognosis may not be as bleak (*although
Vaccines, maintenance, and PEP
The information below is provided for informational purposes only and does not represent treatment or vaccine guidelines from the AAD. Please refer to your local, state, or national guidelines for treatment and vaccine guidelines. ... 1. What are the guidelines for routine MMR vaccination? ... 1,2 ... The routine vaccination
The rhythm of RIME
By Warren R. Heymann, MD, FAAD March 2, 2022 Vol. 4, No. 9 Mucosal ulceration urgently gets everyone’s attention. How many times have you been asked to evaluate a patient for suspected Stevens-Johnson syndrome (SJS)? It is not always an easy task to differentiate erythema multiforme (EM) from pemphigus vulgaris,
The profound dermatological manifestations of COVID-19 Part VI: Going to the dogs
By Warren R. Heymann, MD July 29, 2020 Vol. 2, No. 30 Disclaimers: This commentary was written on July 12, 2020 for a publication date of July 29, 2020. The issues related to the COVID-19 pandemic are changing rapidly. The content included in this commentary may no longer be factual
Advocacy Update Jul 22, 2025
IN THIS ISSUE / July 22, 2025 AADA nominates dermatologist for CDC Advisory Committee Aetna expanding E/M downcoding policy Dermatologists urge Massachusetts lawmakers to pass truth in advertising legislation Step therapy reform enacted in Alaska AADA submits comments to HHS on Medicare payment reform and drug shortages Contribute to SkinPAC
Advocacy Update Dec 9, 2025
IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,
Professionalism and Ethics
Ethics and medicine have been intertwined since the dawn of our profession. From the ancient Hippocratic Oath to the principle of ... primum non nocere to modern-day principlism, medical ethics have evolved over time. ... As public and professional interest in medical ethics increases, it is important for clinicians, researchers,
September 22, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 22, 2021 ... What treatment is most effective for refractory spontaneous urticaria? DermWorld Insights and Inquiries : Following up on "A Trend I Cannot Endorse" DermWorld Young Physician Focus :
Bringing pigmented lupus to light
By Warren R. Heymann, MD Dec. 7, 2017 ... Cutaneous lupus. Biopsy of the left distal thigh shows interface dermatitis, dyskeratosis, superficial perivascular lymphocytic infiltrate, focal red blood cell extravasation, and pigment incontinence. ... Credit: ... JAAD Lettie (not her real name) was an elderly, charming, courtly, soft-spoken African-American woman
Types of audits
RAC audits: In a nutshell ... There are four different types of Medicare contractors that are responsible for auditing records, claims, and payments. ... You need to notify your MAC if you notice errors during a self-audit. ... It doesn’t matter whether you are being audited for the first time
Propranolol for infantile hemangiomas: Start to finish
By Warren R. Heymann, MD, FAAD March 26, 2025 Vol. 7, No. 12 "We have observed that propranolol can inhibit the growth of these [infantile capillary] hemangiomas." (1) In my career, I cannot think of any statement that led to such a swift, dramatic paradigm shift in management more than
After 23 years, a syndrome converted me into an eflornithine believer
By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.
Sweating over sweat gland carcinomas: Part 2 — Eccrine mucin-producing sweat gland carcinoma
By Warren R. Heymann, MD, FAAD Aug. 20, 2025 Vol. 7, No. 33 As I write this commentary, March Madness is underway. According to the NCAA, the odds of predicting all 63 NCAA tournament games correctly are approximately 1 in 9.2 quintillion (a quintillion is 10 to the 18th power).
Advocacy Update Mar. 18, 2025
IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key
Advocacy Update Feb. 18 2025
IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to
The opioid epidemic: Coma blisters and beyond
By Warren R. Heymann, MD Aug. 4, 2017 The opioid crisis in the United States is responsible for at least 90 fatalities every day. This dire situation has been aggravated by the increased availability of very potent synthetic opioids such as fentanyl and carfentanil, which are 50 and 5000 times
How dry I am: The white scale sign of xerosis
By Warren R. Heymann, MD Dec. 22, 2016 When winter approaches my skin dries out. Fortunately, it doesn’t bother me at all. For others, especially in the elderly, xerosis be a predisposing factor for asteototic eczema, nummular dermatitis or dyshidrotic eczema (1). With so many people presenting with dry
March 25, 2026
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / March 25, 2026 ... Finasteride and dutasteride: Depression, suicidal ideation DermWorld What’s Hot: Need for expanded patch testing FDA approves icotrokinra for plaque psoriasis Cutaneous malignancy after biologic therapy Adverse events
Taking psoriasis by the throat
By Warren R. Heymann, MD Nov. 2, 2016 Once the transient satisfaction of explaining the association of streptococcal infections with psoriasis (guttate, vulgaris, or pustulosis palmaris et plantaris) passes, the reality of treatment must be addressed. Of course we’ll prescribe the usual regimens — topical steroids, phototherapy, retinoids, biologics, etc.,
Clinical and therapeutic judgment regarding confluent and reticulated papillomatosis of Gougerot and Carteaud
By Warren R. Heymann, MD, FAAD Feb. 5, 2025 Vol. 7, No. 5 Congratulations to Aaron Judge for setting the American League seasonal record in 2023 for the most home runs — 62 — a remarkable feat. I was only six years old when Roger Maris* slammed his 61st home
A bridge from the view: Switching from glass to digital dermatopathology
By Warren R. Heymann, MD Nov. 23, 2016 Eight months ago, I started using the Clearpath digital dermatopathology system developed by Tom Olsen and his associates at the Dermatopathology Laboratory Central States (DLCS). As one of the early utilizers, I was grateful to work with his software wizards, offering my
Truth in advertising
... Alabama Licensure identification Board certification (BC) Derm-specific BC Misleading advertising Licensees are prohibited from using a title in which in any way represents such person as engaged in the practice of any branch of the healing arts for which such person holds no license. ... n/a ... n/a
No Surprises Act
The No Surprises Act (NSA) provides patients with new protections against surprise billing because of insurance network rules. Like other clinicians, dermatologists must follow new NSA rules beginning on Jan. 1, 2022. The rules were issued jointly by HHS and agencies in the Labor and Treasury departments. ... The NSA
January 6, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Jan. 6, 2021 ... Managing pain in hidradenitis suppurativa patients: A proposed algorithm DermWorld Insights and Inquiries : Itching to see if polymerase chain reaction mite be the future of diagnosing
September 15, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Sept. 15, 2021 ... Worsening psoriasis after COVID-19 vaccination DermWorld Insights and Inquiries : Is ivermectin an old drug with new tricks? Frontal fibrosing alopecia and facial care products Biden administration
Crystallizing thoughts about crystalglobulinemia
By Warren R. Heymann, MD Dec. 14, 2017 ... A, Necrotic purpuric lesions on the dorsum of the foot in a patient with crystalglobulinemia. The thumb had been previously amputated because of necrotic gangrene secondary to occluded vessels. B, Histopathologic features in cutaneous lesions of crystalglobulinemia. Scanning power showing a
Elmer Fudd beware: Tularemia’s re-emergence
By Warren R. Heymann, MD Sept. 24, 2018 Ulcer on left thumb of patient with ulceroglandular tularemia. ... Credit: ... JAAD Practicing dermatology is humbling business. I tip my hat to Polat et al, who diagnosed tularemia in an 11 year-old girl presenting with targetoid papules and plaques of her
Predicting malignancies in Sweet syndrome has become sweeter
By Warren R. Heymann, MD Feb. 8, 2018 Histiocytoid Sweet syndrome. A, Multiple round erythematous papules and plaques on trunk and upper limbs. B, Multiple erythematous papules and plaques grouped in figurate pattern on the right thigh of a pediatric patient. C, Erythematous figurate annular plaques with erythematous elevated borders
Darier disease is rough clinically and therapeutically. MEK inhibition may offer a smoother future
By Warren R. Heymann, MD, FAAD Dec. 4, 2024 Vol. 6, No. 48 Consultative medical dermatology is stressful because challenging patients come with high hopes. Usually, the referring dermatologist is thorough, thoughtful, and on-target diagnostically and therapeutically. The key is setting expectations — if the dermatosis is easily manageable, they
Surviving and thriving after a natural disaster
Answers in Practice ... By Emily Margosian, Assistant Editor, September 1, 2023 DermWorld ... talks to Mary Lupo, MD, FAAD, from the Lupo Center for Aesthetic and General Dermatology in New Orleans, about how to prepare your practice for a natural disaster. Mary Lupo, MD, FAAD ... DermWorld: Tell us
Educating the public – Choose a derm
Choose A Dermatologist campaign increases public awareness of dermatology ... Every month, our public education social posts are seen by 1.75 million people on Instagram, Twitter, and Facebook! Through the Choose A Dermatologist campaign, we empower you to communicate the value of choosing a dermatologist on your individual channels so
Slivers of skin may diagnose silver hair syndromes
By Warren R. Heymann, MD Jan. 7, 2019 As my hair gets progressively grayer trying to keep up with molecular advances in dermatology, it is refreshing to read how simple tests may help distinguish the rare silver hair syndromes (SHS): Chediak-Higashi (CHS) and Griscelli (GS). ... CHS is an autosomal
Standard postoperative wound care practice may be all wet
By Warren R. Heymann, MD, FAAD July 9, 2025 Vol. 7, No. 27 Dermatologists perform procedures throughout the day, including straightforward skin biopsies, electrodesiccation, curettage, cryosurgery, laser treatments, etc. Postoperatively, many of these wounds are dressed, and patients are given instructions for caring for them. ... The following, entitled "After
CMS prior authorization final regulation incorporates AADA’s recommendations
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, July 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. The AADA advocated tirelessly for prior authorization reform. As a result, several policy changes will take
Differentiating lichen planopilaris from chronic cutaneous lupus may be as easy as 1,2,3 (actually CD123)
By Warren R. Heymann, MD June 4, 2016 My last dermatopathology case of the week was that of a woman with scarring alopecia, which was clearly well advanced. Hardly any follicles remained, and on one section there was a small follicular unit with a peri-infundibular mononuclear infiltrate and slight vacuolar
May 12, 2021
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 12, 2021 ... Telogen effluvium diagnosis during the COVID-19 pandemic DermWorld Insights and Inquiries : For patients with erythropoietic protoporphyria the tide has come in Derm Coding Consult : How
August 13, 2025
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / Aug. 13, 2025 ... Effects of GLP-1RA on inflammatory skin diseases DermWorld Insights and Inquiries : Sweating over sweat gland carcinomas: Part 1 — Squamoid eccrine ductal carcinoma Beta-HPV virus can
Impact Report — Vol 3, Issue 2
Seen, heard, valued. It all adds up. Whether it’s advocating for you on the Hill, supplementing our coding resources, positioning the specialty, or enhancing and adding to your member benefits, it all builds something bigger and stronger for dermatology. ... Read about our most current advocacy efforts, specialty positioning initiatives,
Impact Report — Vol 3, Issue 1
We are building a brighter tomorrow, today. Our bright tomorrow is forged and reinforced by the work we do all year to make the Academy strong. The efforts and successes involve AAD staff, working alongside leadership and, importantly, members like you. It’s a powerful collaboration. ... In this edition of
Impact Report — Vol 4, Issue 3
At the Academy, our number one priority is to support our members. To do that, we are consistently evaluating our initiatives and programs to ensure you are getting the most from your membership. See how we support you through advocacy, read about our success in positioning your expertise with the
Impact Report — Vol 5, Issue 3
Your Academy continues to protect and advance our specialty where it matters most. We advocated for fair payment, defended against inappropriate step therapy protocols, raised the visibility of dermatology, expanded CME access, and strengthened our member community. ... This issue of the ... Impact Report highlights the measurable results of
Impact Report — Vol 3, Issue 2
Seen, heard, valued. The AAD/A ... Impact Report isn’t just a chronicle of Academy wins for our members (although it is ... that, too), it’s an ongoing confirmation that we are listening to you, responding to your needs, and giving you the tools you require to grow in your profession.
Treating metastatic melanoma: Understanding a brave new world
Acta Eruditorum ... Dr. Schwarzenberger is the former physician editor of ... DermWorld . She interviews the author of a recent study each month. ... By Kathryn Schwarzenberger, MD, April 2, 2018 In this month's Acta Eruditorum column, Physician Editor Kathryn Schwarzenberger, MD, talks with Jane Grant-Kels, MD, and Daniel
The many uses of microneedling
Go to AAD Home ... Go to AAD Home ... Menu ... How it works, potential applications, and what patients should know ... How it works, potential applications, and what patients should know ... By Emily Margosian, assistant editor Once an experimental treatment pioneered through the use of tattoo pistols
Quality Resources Provided by the AAD
Quality Measures ... AAD continues to develop ... dermatology-specific measures available to dermatologists . Dermatology measures are needed to meet CMS reporting requirements, can be used to drive quality improvement, and may be required by additional organizations. ... Learn more about quality measures available for reporting, a ... measure selection
The expanding horizon of anti-IL-36 therapy
By Warren R. Heymann, MD, FAAD Sept. 25, 2024 Vol. 6, No. 39 An abridged version of this commentary was published in "A Clinician’s Perspective" in the April 2024 issue of the JAAD ... . We last explored the relationship between IL-36 and generalized pustular psoriasis (GPP) and the use
May 25, 2022
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / May 25, 2022 ... Placebo regrowth rate in alopecia areata trials DermWorld Insights and Inquiries : The globalization of monkeypox AADA renews calls for iPLEDGE improvements with IPMG, FDA Seeking comments
Diagnosing the primary cutaneous SMARCA4-deficient cutaneous tumor: You don’t know what you got ‘til it’s gone
By Warren R. Heymann, MD, FAAD Nov. 5, 2025 Vol. 7, No. 44 Understandably, dermatologists are often surprised to receive a histopathologic diagnosis of Merkel cell carcinoma, given the relatively nondescript clinical features that suggest a basal cell carcinoma or inflamed cyst. The purpose of this commentary is to introduce
A string of (clinical) pearls about drug-induced linear IgA disease
By Warren R. Heymann, MD Aug. 6, 2018 Linear IgA dermatosis patient with urticarial eruption of the trunk. ... Credit: ... JAAD The late sage Wallace Clark taught me that once a diagnosis is secured, thinking ceases. Admittedly in cases of drug-induced linear IgA dermatosis (DI-LAD) that I have encountered
Dermatologists cannot be lax about acquired cutis laxa
By Warren R. Heymann, MD Jan. 28, 2019 Acral localized acquired cutis laxa. Loose, redundant skin on the volar finger pads bilaterally that gave them a flat, rounded appearance. ... Credit: ... JAAD From the time I was a medical student, I have always been fascinated by the "little old
Turning a blind eye on second opinions
By Warren R. Heymann, MD, FAAD June 21, 2023 Vol. 5, No. 25 Whenever I encounter patients who ask for, or are being seen for, second opinions, I silently chuckle at Henny Youngman’s timeless one-liner about the subject (you can Google it). The fact is that second opinions are no
I never wanted chaperones — until now
By Warren R. Heymann, MD Sept. 25, 2019 Vol. 1, No. 29 My oldest brother George had just gotten his driver’s license — under no circumstances would my mother allow him to drive his date Ruth to the movies. George protested vehemently, but ultimately relented, with my mother sitting in
This month’s news from across the specialty
What’s hot ... June 1, 2026 In this monthly column, members of the DermWorld ... Editorial Advisory Workgroup identify exciting news from across the specialty. Emily Chu, MD, PhD, FAAD Genetic alterations underpinning melanoma have been increasingly well characterized over the last two decades — most notably point mutations
The appeal of molecular medicine for the peeling skin syndrome
By Warren R. Heymann, MD April 17, 2018 A, After soaking his foot in warm water for 30 minutes, the patient could peel superficial layers of skin. B, After the peeling, erythematous base is revealed. C, Healed area with slight thickening and pigmentation. ... Credit: ... JAAD This may not
Raising a toast to advances in treating alcohol-induced flushing
By Warren R. Heymann, MD November 11, 2020 Vol. 2, No. 45 Whether with pride or embarrassment, we have all blushed. Also known as flushing, the process is defined as a visible reddening of the skin accompanied by a sensation of warmth, characteristically affecting the face, ears, neck, and upper
A sweeter approach to treating scleroderma?
By Warren R. Heymann, MD March 14, 2017 Scleroderma fingernail changes. A, Longitudinal ridging and pitting. B, Brachyonychia. C, Trachyonychia. D, Thickened and enlarged cuticles. E, Thickened, enlarged, and irregular cuticles. F, Nailfold capillaroscopy: presence of enlarged and giant capillaries. G, Nailfold capillaroscopy: presence of enlarged and giant capillaries,
This month’s news from across the specialty
What’s hot ... August 1, 2023 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Craig Burkhart, MD, MS, MPH, FAAD SARMs is a growing and dangerous social media trend. ... The U.S. Food and Drug Administration (FDA)
This month’s news from across the specialty
What’s hot ... October 1, 2024 In this monthly column, members of the ... DermWorld Editorial Advisory Workgroup identify exciting news from across the specialty. ... Mallory Abate, MD, FAAD How highly hereditable is melanoma? Prior studies have estimated that genetic predisposition is rare, with as few as 2.5%
The illusions of IgG4-related skin disease
By Warren R. Heymann, MD, FAAD Dec. 10, 2025 Vol. 7, No. 48 "The greatest enemy of knowledge is not ignorance; it is the illusion of knowledge." – Stephen Hawking Prior to researching this commentary, I had illusions that I grasped the fundamental concepts of IgG4-related disease (IgG4-RD); after writing
Research suggests connection between hair loss in women and other diseases
Board-certified dermatologist discusses common types of hair loss seen in women with darker skin tones NEW ORLEANS (March 17, 2023) — Hair loss in women can be emotionally devastating and may negatively impact quality of life, and new research suggests that it can also be associated with having other common
Necrotizing infundibular crystalline folliculitis: Not yet crystal clear
By Warren R. Heymann, MD, FAAD Jan. 29, 2025 Vol. 7, No. 4 Time and exposure to several articles are necessary to crystallize a novel clinicopathological correlation in my mind. Such is the case with necrotizing infundibular crystalline folliculitis (NICF). I suspect that I have seen this condition but have
Step 3: Small and large practice reporting options
Access the PDF ... See a PDF version of the Academy ... ’ s ... practice reporting options . ... Review these reporting options for small practices (15 providers or fewer) and large practices (16 providers or more) to help achieve the minimum and maximum points needed to either avoid
Step 3: Small and large practice reporting options
Access the PDF ... See a PDF version of the Academy ... ’ s ... practice reporting options . ... Review these reporting options for small practices (15 providers or fewer) and large practices (16 providers or more) to help achieve the minimum and maximum points needed to either avoid
The pregnant pause in cutaneous lymphoma
By Jennifer Villasenor-Park, MD, FAAD Oct. 2, 2024 Vol. 6, No. 40 I first met Anne when she was 30 years old and was experiencing a significant flare of her mycosis fungoides. She had already lived with the disease for 18 years having been diagnosed at the age of 12
Of every possible solution for elastosis perforans serpiginosa, fractional carbon dioxide laser may be the best
By Warren R. Heymann, MD Nov. 13, 2017 ... Elastosis perforans serpiginosa. Clinical presentation. ... Credit: ... JAAD My initial attraction to dermatology, which still offers great appeal, is the challenge and joy of differential diagnosis and clinical-pathologic correlation. I learned quickly, however, that patients don’t want to be interesting
July 15, 2020
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... IN THIS ISSUE / July 15, 2020 ... JAAD study demonstrates link between chilblains and COVID-19 DW Insights and Inquiries: Incysting on understanding pilar cysts Derm Coding Consult : Practical applications of 2021 E/M coding
The Venetian antithesis: Treating median canaliform nail dystrophy
By Warren R. Heymann, MD, FAAD Oct. 4, 2023 Vol. 5, No. 40 Tony Bennett may have left his heart in San Francisco, but mine remains in Venice. ... (The editorial staff of DWI&I offer our sincerest condolences to the families of those who perished, and our prayers for recovery
Striving to alleviate the physical and emotional scars of central centrifugal cicatricial alopecia
By Warren R. Heymann, MD November 4, 2020 Vol. 2, No. 44 More than half a century ago, Drs. Lopresti, Papa, and Kligman coined the term "hot comb alopecia," asserting: "The cause is unmistakable, namely the practice of straightening the hair with a hot comb…" (1). Now known as central
A potential roadMAP for treating malignant atrophic papulosis
DermWorld Insights and Inquiries ... By Warren R. Heymann, MD, FAAD, June 1, 2026 Vol. 8, No. 6 Certain skin lesions evoke dread in the dermatologist who encounters them, fearing a poor prognosis for their patient. Examples include a Sister Mary Joseph nodule, a thick melanoma, or rhinocerebral mucormycosis, among
Congenital juvenile xanthogranulomas: Born to be wild (but ultimately mild)
Positivity for CD68 stain is limited in center of specimen, where changes of juvenile xanthogranuloma exist. ... Credit: JAAD ... By Warren R. Heymann, MD Dec. 17, 2018 "Lost to follow-up" has implications that go beyond the obvious. Following up with patients is an essential part of learning for physicians
Breaking through
Go to AAD Home ... Go to AAD Home ... Menu ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... Advances in disease pathogenesis and treatments offer new promise for patients with connective tissue disease ... By Allison Evans, assistant managing editor
Why you should hear about the red ear syndrome
By Warren R. Heymann, MD July 22, 2020 Vol. 2, No. 29 Is it my imagination that the "by the way" comments at the presumed end of a patient encounter cause the most angst? Usually, it’s something like "Oh, I forgot to mention that I’m losing my hair!" Recently, at
2025 MIPS and telehealth highlights
Eligibility criteria ... The low volume threshold remains the same as in 2025 and includes three aspects of covered professional services: ... Allowed charges ... Number of Medicare patients who receive services ... Number of services provided ... You must participate in MIPS (unless otherwise exempt) if, in both 12-month
Recognizing Trichophyton indotineae
Reporting to health departments ... Physicians who suspect antimicrobial-resistant dermatophytosis can also contact ... their state or local health departments for assistance . Public health officials who are concerned about potential cases or clusters of drug-resistant tinea infections can email ... fungaloutbreaks@cdc.gov for assistance with recommendations and testing. ... Overview
Top 3 administrative burdens in dermatology and how to tackle them!
Answers in Practice ... By Faiza Wasif and Swapna Pachauri, AADA Practice Management, December 1, 2021 Each month, DermWorld ... tackles issues "in practice" for dermatologists. This month, practice management staff offer tips on managing the top three administrative burdens. A successful dermatology office is established not only on optimal
Avoid the opioid
Experts offer advice on effective pain management in dermatology. ... Feature ... By Heidi Splete, Contributing Writer, May 1, 2026 Many dermatoses and dermatologic procedures are painful, but consensus on pain management in dermatology is limited, and complicated not only by the individual and varied experience of pain, but also
CMS Pays for Communication Technology-based Services, Effective 2019
Given the recent ubiquitous nature of synchronous audio and video applications available for download and the increased use of patient-facing health portals, the Center for Medicare & Medicaid Services (CMS) has determined that a broad range of services can be provided by healthcare professionals via communication technology. ... Remote Evaluation
Oncolytic virotherapy and the dermatologist
By Warren R. Heymann, MD March 8, 2018 My late British cousin Tim, a brilliant, kind, benevolent husband, father, gastroenterologist, and MBA, lost his battle with glioblastoma in 2016 at age 55.* I was hoping that he might be able to get into a trial using an oncolytic virus (OV),
Sirolumus’s merit for the Kasabach-Merritt phenomenon
By Warren R. Heymann, MD Oct. 8, 2018 KHE patient after 15 months of sirolimus therapy. ... Credit: ... JAAD Thrombopenic purpura associated with benign hemangioma is rare. In fact, we have not been able to find a record of a combination of these two conditions in the medical literature.
Learning about proton pump inhibitor-induced dermatologic adverse reactions is ulcerogenic
By Warren R. Heymann, MD June 7, 2016 How many of your patients are on protein pump inhibitors (PPI) such as Nexium [esomeprazole], Prevacid [lansoprazole], or Prilosec [omeprazole] for GERD? Let me rephrase the question. How many of your patients are NOT on PPIs? ... Alkeraye et al reported two
Rituximab and dermatomyositis: Dr. Samitz would be proud
By Warren R. Heymann, MD Nov. 20, 2019 Vol. 1, No. 37 The gifted dermatologist clinician-educator Morris H Samitz, MD, has been honored with an annual lectureship at the Perelman School of Medicine at the University of Pennsylvania for the past 44 years. Dr. Samitz passed away in 1993, but
A tale of two disorders of hypopigmentation: The potential role of Cutibacterium acnes dysbiosis in progressive macular hypomelanosis and lichen striatus
By Warren R. Heymann, MD, FAAD April 30, 2025 Vol. 7, No. 17 The human microbiome of the skin, gastrointestinal tract, and airways comprises distinct populations of bacteria, fungi, viruses, and mites and plays an essential role in homeostasis. The skin microbiome represents the totality of microbial genes within the
Key messages when communicating about skin cancer
Key messages ... Skin cancer is the most common cancer in the United States, with millions of cases diagnosed each year. It’s also one of the most preventable cancers and highly treatable when found early. ... To reduce your risk of skin cancer, seek shade, wear protective clothing and apply
A novel sebum inhibitor for acne vulgaris: A slick maneuver
By Warren R. Heymann, MD Jan. 11, 2017 Illustrative photos of severe inflammatory acne vulgaris, largely without nodules (A). B, Very severe acne with cysts. ... Credit: ... JAAD What a pleasure it is to think about a novel treatment for acne! Honestly, have you gotten excited learning that the
Tarrying for tapinarof
By Warren R. Heymann, MD, FAAD January 12, 2022 Vol. 4, No. 2 Today we held our first round of interviews for our dermatology residency program for 2023. Meeting dermatology resident applicants is a delight — they are brilliant, engaging, and a source of pride for our discipline. We started
Step 1: Check participation requirements
MIPS 2026 Reporting Snapshots ... Access our 2026 ... MIPS reporting options (PDF), with guidance tailored to your practice size and needs. ... First, determine if you are exempt from MIPS reporting. ... Use the tool below to check whether you are required to participate in MIPS. CMS uses your
Increasing evidence for the use of topical timolol for pyogenic granulomas
By Warren R. Heymann, MD May 16, 2016 There are multiple approaches to treating pyogenic granulomas (PGs). If possible, I usually perform a shave biopsy and electrodesiccate the base of the lesion. Certainly there are times when that approach may not be optimal, such as a PG the face of
Preventing and treating Trichophyton indotineae
Prevention ... Specific recommendations to prevent ... T. indotineae infection do not exist, but physicians can educate patients about strategies for ... preventing dermatophyte infections in general. ... Health care professionals should use ... Standard Precautions when caring for patients with possible tinea. ... Empiric treatment ... Because confirmatory testing
Tackling itch
Understanding and treating chronic itch ... Feature ... By Allison Evans, Assistant Managing Editor, April 1, 2022 Itch, or pruritus, is a common symptom (and condition) that is considered one of the 50 most prevalent conditions worldwide — an estimated 15% of the population suffers from chronic pruritus. Speak to
Medical vs. cosmetic dermatology: Who is doing what?
Facts at your Fingertips ... By Emily Margosian, assistant editor, January 1, 2019 Despite ongoing discussion about the role of cosmetics in the specialty, data from the 2017 AAD Practice Profile Survey indicate that medical dermatology remains the primary focus of dermatology practitioners across all types. However, dermatologists spend the